carbidopa, levodopa drug combination and Parkinson Disease

carbidopa, levodopa drug combination has been researched along with Parkinson Disease in 494 studies

*Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) [MeSH]

Research

Studies (494)

Timeframe	Studies, this research(%)	All Research%
pre-1990	100 (20.24)	18.7374
1990's	98 (19.84)	18.2507
2000's	28 (5.67)	29.6817
2010's	228 (46.15)	24.3611
2020's	40 (8.10)	2.80

Authors

Authors	Studies
Ando, R; Hosokawa, Y; Miyaue, N; Nagai, M; Tada, S; Yabe, H; Yamanishi, Y; Yoshida, A	1
Adar, L; Caraco, Y; Case, R; Djaldetti, R; Giladi, N; Gurevich, T; Leibman-Barak, S; Sasson, N	1
Danoudis, M; Iansek, R; Paul, E; Sung, CB	1
Aldred, J; Anca-Herschkovitsch, M; Ballina, M; Bergmann, L; Bourgeois, P; Chaudhuri, KR; Cubo, E; Davis, TL; Iansek, R; Jia, J; Kovács, N; Kukreja, P; Ladhani, O; Pontieri, FE; Siddiqui, MS; Simu, M; Standaert, DG	1
Bancila, I; Ciocîrlan, M; Cotruta, B; Dobru, D; Drug, V; Dumitru, E; Gheorghe, C; Goldis, A; Jinga, M; Manuc, M; Mercea, VA; Pitigoi, D; Saftoiu, A; Seicean, A; Tanțău, M	1
Almeida, L; Barabas, M; Eisinger, RS; Elkouzi, A; Malaty, IA; Okun, MS; Ramirez-Zamora, A; Zeilman, P	1
Hoy, SM	1
Ares-Pensado, B; Castro, A; Fernandez-Pajarin, G; Rivero-de-Aguilar, A; Sesar, A	1
Fernández García, J; García Hernández, M; Garrido Durán, C; Khorrami Minaei, S; Legarda Ramírez, I; Sendra Rumbeu, P	1
Alam, M; Rönnegård, L; Saqlain, M; Westin, J	1
Chang, FCF; Fung, VSC; Galea, D; Griffith, J; Ha, AD; Kim, SD; Mahant, N; Morales-Briceño, H; Tsui, D	1
Artusi, CA; Balestrino, R; Bortolani, S; Fabbri, M; Imbalzano, G; Lopiano, L; Montanaro, E; Tuttobene, S; Zibetti, M	1
Baille, G; Blaise, AS; Carrière, N; Defebvre, L; Devos, D; Dujardin, K; Grolez, G; Kreisler, A; Kyheng, M; Moreau, C; Mutez, E; Seguy, D	1
Akbostanci, MC; Bilgiç, B; Bora Tokçaer, A; Çakmur, R; Doğu, O; Elibol, B; Erer Özbek, ÇS; Gültekin, M; Hanağasi, H; İnce Günal, D; Kenangil, G; Mirza, M; Tezcan, S; Ulukan, Ç; Yilmaz Küsbeci, Ö	1
Arca, R; Cossu, G; di Biase, L; Di Lazzaro, V; Di Santo, A; Fasano, A; Marano, M; Marano, P; Naranian, T; Poon, YY	1
Jalundhwala, YJ; Lakdawalla, DN; Marshall, TS; Sail, KR; Shih, TM; Sullivan, J; van Eijndhoven, E; Zadikoff, C	1
McFarthing, K; Prakash, N; Simuni, T	1
Belcaro, G; Cesarone, MR; Cotellese, R; Feragalli, B; Hosoi, M; Hu, S; Ledda, A; Maione, C; Scipione, C; Scipione, V	1
Stocchi, F; Vacca, L	1
Armstrong, MJ; Okun, MS	1
Chen, HJ; He, JC; Jiang, ZY; Wu, K; Xie, CL; Zhang, XR; Zhang, ZR	1
Cerroni, R; Imbriani, P; Liguori, C; Mercuri, NB; Pierantozzi, M; Pisani, A; Scalise, S; Stefani, A	1
Paik, J	1
Ehlers, C; Honig, H; Odin, P; Timpka, J	1
Bloem, BR; Nonnekes, J	1
D'Souza, R; Fisher, S; Hauser, RA; Zeitlin, L	2
Chaudhuri, KR; Jones, S; Leta, V; Parry, M; Rizos, A; Sauerbier, A; van Wamelen, DJ	1
Boettcher, L; Edinger, G; Erickson, LO; Gardner, J; Kitzmann, R; Nance, MA; Wichmann, R; Wielinski, CL	1
de Bie, RMA; Dijk, JM; Espay, AJ; Katzenschlager, R	1
Adnan, M; Nyholm, D; Senek, M	1
Drent, M; Groenendal-Laurensse, JWMJ; Moes, HR; Tissingh, G; van Laar, T	1
Altiparmak, E; Erdoğan Küçükdağli, F; Köseoğlu, HT; Öztürk, Ö; Saltoğlu, T; Sücüllü Karadağ, Y	1
Arnold, AC; De Jesus, S; Delnomdedieu, M; Duvvuri, S; Eslinger, PJ; Fernandez-Mendoza, J; Gray, DL; Harrington, W; Huang, X; Kong, L; Lewis, MM; Mahoney, SE; Mailman, RB; Miller, AJ; Snyder, B; Sun, D; Van Scoy, LJ; Wang, X	1
Nielsen, EI; Nyholm, D; Senek, M	3
Adar, L; Case, RJ; Ellenbogen, AL; Espay, AJ; Leinonen, M; Olanow, CW; Oren, S; Orenbach, SF; Poewe, W; Stocchi, F; Yardeni, T	1
Leucuta, DC; Perju-Dumbrava, L; Popa, LC; Popa, SL; Tohanean, N	1
Carroll, DG; Halli-Tierney, AD; Luker, J	1
Gillespie, A; Jones, E; Pappert, E; Pike, J; Thach, A; Wright, J	1
Guillén Climent, S; Monteagudo, C; Pinazo Canales, MI; Porcar Saura, S	1
Athanasakis, E; Avgoustaki, A; Boura, I; Chlouverakis, G; Giakoumakis, E; Giannopoulou, IA; Koulentaki, M; Orfanoudaki, E; Spanaki, C	1
Carr, RA; Enright, BP; Facheris, MF; Jameel, F; Kym, PR; Liu, W; Lou, X; Mayer, PT; Moussa, EM; Rosebraugh, M; Stolarik, D; Voight, EA; Zhang, GGZ	1
Babu, S; Chang, FC; Dal, S; Fletcher, N; Fung, VSC; Mahant, N; Martin, AJ; Morales-Briceno, H; Nankervis, J; Ong, TL; Robbie, M; Williams, LJ	1
Khurana, N; Muthuraman, A; Sharma, N; Utreja, P	1
Benner, J; Jalundhwala, YJ; Lakdawalla, DN; Marshall, TS; Sail, KR; Shih, TM; Sullivan, J; van Eijndhoven, E; Zadikoff, C	1
Comella, CL; Hauser, RA; LeWitt, PA	1
Fujioka, S; Fukuchi, T; Furukawa, K; Furune, S; Ikeda, Y; Jin, X; Kato, M; Koike, T; Kubota, E; Murakami, H; Sato, Y; Suzuki, T; Tsuboi, Y; Uehara, T; Yamashita, K; Yamazaki, Y; Yube, Y	1
Baig, F; Boca, M; Cheminais, L; Collin, N; Mooney, L; Rolinski, M; Selikhova, M; Szewczyk-Krolikowski, K; Whone, A	1
Fasano, A; Naranian, T; Poon, YY; Rohani, M	1
Aasly, J; Dietrichs, E; Egge, A; Ezat, B; Pihlstrøm, L; Tysnes, OB	1
Ehm, G; Jeon, B; Kim, A; Kim, HJ; Kim, YE; Lee, WW; Yang, HJ; Yun, JY	1
Chorbadzhieva, E; Dressler, D; Kleimann, A; Loens, S; Schrader, C	1
Capone, JG; Golfrè Andreasi, N; Preda, F; Rispoli, V; Sensi, M; Sette, E; Simioni, V; Tugnoli, V	1
Bove, F; Di Iorio, R; Fasano, A; Gallicchio, L; Luigetti, M; Petruzzellis, A; Recchia, V; Tamma, F	1
Durando, M; Kim, JS; Tiu, H	1
Bentivoglio, AR; Bove, F; Fasano, A; Naranian, T	1
Eerola-Rautio, J; Kenttämies, A; Kylänpää, L; Lindström, O; Lyytinen, J; Pekkonen, E; Udd, M	1
Ando, R; Miyaue, N; Nagai, M; Nishikawa, N; Nomoto, M; Tada, S; Yabe, H	1
Mundt-Petersen, U; Odin, P	1
Abu-Suboh, M; Alvarez-Sabín, J; Armengol, JR; De Fabregues, O; Dot, J; Ferré, A; Gómez, MR; Hernández-Vara, J; Ibarria, M; Puiggros, C; Quintana, M; Raguer, N; Romero, O; Seoane, JL	1
D'Elia, A; Imbriani, P; Pisani, A; Schirinzi, T	1
Baj, R; Chaudhuri, KR; Jalundhwala, YJ; Konwea, H; Lowin, J; Marshall, TS; Sail, K	1
Dizdar, N; Grenholm, P; Groth, K; Kjellander, S; Larsson, J; Nyholm, D; Permert, J; Schmiauke, U; Urbom, A; Widner, H; Willows, T	1
Antonini, A; Barch, D; Bergmann, L; Chaudhuri, KR; Jech, R; Odin, P; Onuk, K; Pickut, B; Pirtošek, Z; Poewe, W; Szasz, J; Valldeoriola, F; Winkler, C; Yegin, A	1
Fasano, A; Jog, M; Kumar, N; Murgai, A; Naranian, T	1
Hoon, M; Petzer, A; Petzer, JP; Viljoen, F	1
Compta, Y; Martí, MJ; Muñoz, JE; Ríos, J; Rumià, J; Santacruz, P; Tolosa, E; Valldeoriola, F	1
Fairchild, A; Hass, S; Marshall, T; Pugh, A	1
Barichella, M; Cassani, E; Cereda, E; Cilia, R; Laguna, J; Pezzoli, G; Raspini, B	1
Angrisano, S; Artusi, CA; Dematteis, F; Lopiano, L; Merola, A; Romagnolo, A; Zibetti, M	1
Esqueda-Liquidano, M; García-Gomar, MG; Velasco, AL; Velasco, F	1
Bakis, G; Nutt, J; Staisch, J	1
Antonini, A; Canesi, M; Costanzo, AM; Defazio, G; di Luzio Paparatti, U; Gualberti, G; Latorre, A; Lopiano, L; Marano, P; Melzi, G; Modugno, N; Pontieri, FE; Quatrale, R; Sensi, M; Solla, P; Tambasco, N; Tessitore, A	1
Kundt, FS; Lex, KM; Lorenzl, S	1
Arbelo, JM; Catalan, MJ; Cubo, E; Martinez-Martin, P; Mir, P; Molina-Arjona, JA	1
Eklund, M; Henriksen, T; Nyholm, D; Odin, P; Sahlström, T; Timpka, J	1
Benesh, J; Boyd, JT; Chatamra, K; Eaton, S; Espay, AJ; Facheris, MF; Fernandez, HH; Fung, VSC; Hall, C; Lew, MF; Robieson, WZ; Rodriguez, RL; Slevin, JT; Standaert, DG; Vanagunas, AD; Zadikoff, C	1
Andrisani, G; di Biase, L; Di Lazzaro, V; Di Matteo, FM; Di Santo, A; Marano, M; Martino, M; Pandolfi, M; Pizzicannella, M; Rea, R	1
Bertram, KL; Hewer, S; Lee, W; Ligtermoet, M; Paul, E; Varley, S; Vijiaratnam, N; Williams, DR	1
Sue, CM; Vijiaratnam, N	1
Antonini, A; Bergmann, L; Poewe, W; Robieson, WZ; Yegin, A	1
Bergquist, F; Ericsson, A; Johansson, A; Johansson, D; Medvedev, A; Nyholm, D; Ohlsson, F; Senek, M; Spira, J; Thomas, I; Westin, J	1
Fujioka, S; Fukae, J; Hasegawa, S; Hayashi, Y; Mishima, T; Nose, K; Shiwaku, H; Tsuboi, Y; Umemoto, G; Yamashita, K	1
Ares-Pensado, B; Castro, A; Fernandez-Pajarin, G; Iglesias-Canle, J; Masa-Vazquez, L; Sesar, A	1
Allone, C; Bonanno, L; Bramanti, P; Ciurleo, R; Corallo, F; Di Lorenzo, G; Lo Buono, V; Marino, S; Palmeri, R; Versaci, R	1
Antonini, A; Kleinman, LS; Marshall, TS; Odin, PLA; Onuk, K; Sail, KR; Skalicky, AM; Stoessl, AJ	1
Anang, JBM	1
Hirozawa, D; Ikenaka, K; Mochizuki, H; Nakano, T; Sasaki, T; Shimamura, M	1
Memedi, M; Nyholm, D; Thomas, I; Westin, J	1
Cowie, F; Grosset, DG; Watson-Fargie, T; White, J	1
Dinh, P	1
Fabbri, M; Ferreira, JJ; Rosa, MM	1
Beccaria, L; Fabbri, M; Ferreira, JJ; Lopiano, L; Merola, A; Montanaro, E; Palermo, S; Romagnolo, A; Zibetti, M	1
Antonini, A; Bergmann, L; Poewe, W; Ray Chaudhuri, K; Robieson, WZ; Sanchez-Soliño, O	1
Hirata, Y; Ishikawa, H; Kato, N; Matsuura, K; Matsuyama, H; Narita, Y; Niwa, A; Tomimoto, H	1
Baik, JS; Cho, J; Jeon, B; Kim, HT; Kim, JM; Kim, JW; Koh, SB; Kwon, OD; Lee, HW; Lee, JY; Ma, HI; Yoon, WT	1
Christie, M; Coss, P; Ondo, W; Pascual, B	1
Duvvuri, S; Gray, DL; Liu, W; Papapetropoulos, S; Thayer, K	1
Belsey, J; Kalabina, S; Mohamed, B; Paterson, B; Pivonka, D; Thomas, C	1
Antonini, A; Bergmann, L; Chaudhuri, KR; Poewe, W	1
Arbelo, JM; Catalán, MIJ; Grandas, F; Mir, P; Parra, JC; Puente, V; Regidor, I; Santos-García, D; Valldeoriola, F	1
Alam, M; Bergquist, F; Johansson, D; Memedi, M; Nyholm, D; Thomas, I; Westin, J	1
Lees, AJ; Moro, A; Munhoz, RP; Pessoa, RR; Teive, HAG	1
Hideshima, M; Hirozawa, D; Ikenaka, K; Ishikura, T; Kitano, T; Konaka, K; Mochizuki, H; Nakano, T; Shimamura, M; Shinzaki, S; Takehara, T	1
Cabreira, V; Massano, J; Soares-da-Silva, P	1
Mukai, Y; Murata, M; Nishikawa, N; Takahashi, Y	1
Ellenbogen, A; Hauser, RA; Isaacson, SH; Kegler-Ebo, DM; Komjathy, SF; Oh, C; Safirstein, BE; Truong, DD; Zhao, P	1
Artusi, CA; Fabbri, M; Lopiano, L; Pongmala, C; Rizzone, MG; Romagnolo, A; Zibetti, M	1
Di Vico, IA; Novelli, A; Ramat, S; Sorbi, S; Terenzi, F	1
Januário, C; Morgadinho, A; Reis Carneiro, D; Sousa, M	1
Centonze, D; Fasano, A; Femiano, C; Lena, F; Modugno, N; Olivola, E; Santilli, M; Varanese, S	1
Egawa, H; Fukunaga, T; Hatano, T; Hattori, N; Ishibashi, Y; Kaji, S; Kanda, S; Kohira, Y; Oka, S; Oyama, G; Shimo, Y; Yube, Y	1
Antonini, A; Bentivoglio, A; Eleopra, R; Gualberti, G; Gusmaroli, G; Lopiano, L; Mancini, F; Marano, P; Meco, G; Melzi, G; Modugno, N; Quatrale, R; Sensi, M; Solla, P; Tamma, F; Zangaglia, R	1
Giladi, N; LeWitt, PA; Navon, N	1
Duma, S; Fung, VS; Griffith, J; Mahant, N; Martin, A; Morales-Briceño, H; Tsui, D	1
Bartig, D; Gold, R; Jörges, C; Jost, W; Krogias, C; Richter, D; Stumpe, B; Tönges, L	1
Amjad, F; Bhatti, D; Davis, TL; Kukreja, P; Metman, LV; Oguh, O; Pahwa, R; Zamudio, J	1
Antonini, A; Bergmann, L; Kukreja, P; Poewe, W; Robieson, WZ	1
Zesiewicz, TA	1
Gupta, S; Hsu, A; Mao, Z; Modi, NB	1
Ossig, C; Reichmann, H	1
Rascol, O	1
Espay, AJ; Gupta, S; Hauser, RA; Hsu, A; Kell, S; O'Connell, M; Ondo, W; Sethi, K; Stacy, M	1
Worth, PF	1
Agarwal, P; Burdick, DJ; Griffith, A	1
Best, CM; Ifedi, BO; Reichel, LM	1
Filipek, B; Pytka, K; Zygmunt, M	1
Galazky, I; Heinze, HJ; Kluge, C; Kupsch, A; Schoof, J; Stallforth, S	1
Fahn, S; Gupta, S; Hauser, RA; Hsu, A; Jankovic, J; Kell, S; Lyons, KE; O'Connell, M; Pahwa, R; Pourcher, E	1
Angrisano, S; Artusi, CA; De Angelis, C; Lopiano, L; Merola, A; Reggio, D; Rizzi, L; Rizzone, M; Zibetti, M	1
Baumann, CR; Waldvogel, D	1
Chen, D; Cundy, KC; Hauser, RA; Huff, FJ; LeWitt, PA; Lissin, D; Zomorodi, K	1
de Beyl, DZ; Dethy, S; Pickut, BA; Van De Maele, H; van der Linden, C	1
Capone, JG; Contini, E; Golfre-Andreasi, N; Gragnaniello, D; Preda, F; Quatrale, R; Sensi, M; Sette, E; Tola, MR; Trevisani, L; Tugnoli, V	1
Aglan, H; Ahmed, H; Atta, H; Ghazy, M; Salem, A	1
Ceballos-Baumann, AO; Fietzek, UM; Lehnerer, SM; Messner, M	1
Argyris, P; Barla, G; Maltezou, M; Stathis, P; Tzias, V	1
Ahlskog, JE	3
Epstein, J; Hayes, MT; Lai, L; Madiedo, CJ	1
Ondo, W	1
Dillmann, U; Ellenbogen, A; Gupta, S; Hsu, A; Kell, S; Khanna, S; Liang, G; Mahler, A; Rubens, R; Stocchi, F	1
Merello, M; Rossi, M	1
Antonini, A; Poewe, W	1
Benesh, JA; Chatamra, K; Chouinard, S; Dubow, J; Espay, AJ; Fernandez, HH; Fung, VS; Hall, CM; Hauser, RA; Klostermann, F; Lang, AE; Lew, MF; Odin, P; Robieson, WZ; Standaert, DG; Steiger, M; Suchowersky, O; Yakupov, EZ	1
Chang, FC; Drury, M; Fung, VS; Griffith, JM; Ha, AD; Kim, SD; Mahant, N; Tsui, DS; Wolfe, N	1
di Biase, L; Di Lazzaro, V; Marano, M; Melgari, JM; Salomone, G; Scrascia, F	1
Fahn, S; Kestenbaum, M	1
Fasano, A; Lang, AE; Liu, LW; Poon, YY	1
Fung, VS	1
Chen, C; Cowles, VE; Stover, N; Sweeney, M; Verhagen Metman, L	1
Dzyak, L; Gupta, S; Hsu, A; Kell, S; Khanna, S; Nausieda, P; Rudzinska, M; Silver, DE; Spiegel, J; Tsurkalenko, ES; Waters, CH	1
Barrios-Barrios, A; Bustamante-Balén, M; del-Hoyo-Francisco, J; Martínez-Torres, I; Pons-Beltrán, V; Satorres-Paniagua, C	1
Johnson, KE	1
Benedetti, A; Gros, P; Kaminska, M; Kimoff, RJ; Lafontaine, AL; Mery, VP; Robinson, A	1
Cannas, A; Fasano, A; Lang, AE; Marrosu, F; Marrosu, MG; Mulas, CS; Solla, P	1
Bellante, F; Dethy, S; Zegers de Beyl, D	1
Bruno, E; Cicero, CE; Contrafatto, D; Dibilio, V; Giuliano, L; Luca, A; Mostile, G; Nicoletti, A; Pappalardo, I; Raciti, L; Sciacca, G; Sofia, V; Zappia, M	1
Bonuccelli, U; Ceravolo, R; Frosini, D; Mazzucchi, S	1
Katunina, EA; Titova, NV	1
di Biase, L; Di Lazzaro, V; Marano, M; Melgari, JM; Salomone, G	1
Kuoppamäki, M; Leinonen, M; Poewe, W	1
Mick, D; Resan, B; Segec, I; Skelac, D; Soldo, SB; Tomic, S	1
Elmer, L; Gil, RA; Gupta, S; Hsu, A; Kell, S; Khanna, S; Modi, NB; Nausieda, PA; Rubens, R; Singer, C; Spiegel, J	1
Cannas, A; Marrosu, F; Marrosu, MG; Solla, P	1
Bernardini, A; Cocito, D; Lopiano, L; Merola, A; Romagnolo, A; Zibetti, M	1
Abou Al-Shaar, H; Al-Ajlan, F; Alkahtani, K; Alkhairallah, T; Bohlega, S; Hasan, N	1
Mao, ZL; Modi, NB	1
Greig, SL; McKeage, K	1
Benesh, JA; Boyd, JT; Chatamra, K; Chouinard, S; Draganov, PV; Dubow, J; Eaton, S; Espay, AJ; Fasano, A; Fernandez, HH; Fung, VS; Klostermann, F; Lang, AE; Lew, MF; Odin, P; Robieson, WZ; Rodriguez, RL; Schmulewitz, N; Slevin, JT; Stein, DA; Zadikoff, C	1
Băjenaru, O; Buraga, I; Constantinescu, A; Ene, A; Mureşan, DF; Perju-Dumbrava, L; Popescu, BO; Popescu, CD; Sabău, M; Simu, M; Szász, JA	1
Hattori, N	1
Dagher, A; Fellows, LK; Simioni, AC	1
Antonini, A; Benesh, JA; Boyd, JT; Chatamra, K; Eaton, S; Fung, VS; Hall, C; Slevin, JT	1
Mueller, BK; Muhlack, S; Müller, T; Trommer, I	1
Cicero, CE; Mostile, G; Nicoletti, A; Zappia, M	1
Bove, F; Espay, AJ; Espay, KJ; Fasano, A; Krikorian, R; Lena, F; Modugno, N; Poon, YY; Ricciardi, L	1
Dhall, R; Kreitzman, DL	1
Silver, DE; Trosch, RM	1
Benita León, V; Campolongo Perillo, A; Fernández Díez, S; Mariscal Pérez, N; Martínez Castrillo, JC; Puente Périz, V; Santos García, D; Seoane Urgorri, A; Udaeta Baldivieso, B	1
Nyholm, D; Odin, P; Wirdefeldt, K	2
Almeida, L; Falcão, A; Ferreira, JJ; Nunes, T; Pinto, R; Rocha, JF; Santos, A; Soares-da-Silva, P	1
Bernardini, A; Espay, AJ; Espay, KJ; Lanotte, M; Lopiano, L; Merola, A; Rizzi, L; Romagnolo, A; Rosso, M; Zibetti, M	1
Jog, MS; Kumar, N; Rizek, P	1
Lyons, KE; Pahwa, R	1
Abreu, L; Bernardo, C; López Gómez, M; Magaz Martínez, M; Martínez Porras, JL; Santiago, J	1
Mundt-Petersen, U; Odin, P; Timpka, J	1
Bergmann, L; Dizdar, N; Hauge, T; Holmberg, B; Jansson, R; Johansson, A; Kjellander, S; Linder, J; Marshall, TS; Nyholm, D; Pålhagen, SE; Sydow, O; Widner, H	1
Amato, MR; De Micco, R; Del Prete, A; Esposito, P; Ferraro, F; Sica, M; Tessitore, A; Zulli, C	1
Durso, R; McNamara, P; Morgan, J; Smart, K	1
Cubo, E; Giuffrida, JP; Heldman, DA	1
Antonini, A; Cannas, A; Costanzo, AM; di Luzio Paparatti, U; Gualberti, G; Gusmaroli, G; Lopiano, L; Mancini, F; Marano, P; Meco, G; Melzi, G; Modugno, N; Quatrale, R; Sensi, M; Tamma, F	1
Carpenter, MG; Inglis, JT; McKeown, MD; McKeown, MJ; Pasman, EP; Peters, RM	1
Arbelo, JM; Catalán, MJ; Grandas, F; Mir, P; Parra, JC; Puente, V; Regidor, I; Santos-García, D; Valldeoriola, F	1
Bloem, BR; Faber, MJ; Nijhuis, FA; Post, B; van Heek, J	1
Devigili, G; Eleopra, R; Lettieri, C; Rinaldo, S	1
Lambarth, AT	1
Avolio, C; De Francesco, V; Lalla, A; Martino, T; Melchionda, D; Specchio, LM; Tonti, P	1
Bilic, B; Markos, P; Miletic, V; Rustemovic, N	1
Fox, SH; Freitas, ME; Ruiz-Lopez, M	1
Cataldo, BO; Cury, RG; de Campos Duprat, A; Fonoff, E; Noffs, G; Zarzur, AP	1
Bojarski, C; Ehlen, F; Klostermann, F; Maier, A; Marzinzik, F; Schindlbeck, KA	1
Abreu, L; Magaz Martínez, M; Martínez Porras, JL; Oliva, B	1
Borgemeester, R; van Laar, T	1
Cannas, A; Marrosu, F; Mascia, MM; Meloni, M; Solla, P	1
Alonso-Frech, F; Catalán, MJ; Escribano, PM	1
Duker, AP; Ellenbogen, A; Farbman, ES; Gupta, S; Hauser, RA; Hsu, A; Kell, S; Khanna, S; Kreitzman, D; Liang, GS; Nausieda, P; Nieves, A; Rubens, R; Tetrud, J	1
Ács, P; Annus, Á; Aschermann, Z; Dézsi, L; Dibó, G; Harmat, M; Janszky, J; Juhász, A; Karádi, K; Klivényi, P; Komoly, S; Kovács, M; Kovács, N; Makkos, A; Nagy, H; Takáts, A; Tényi, D; Tóth, A; Varannai, L; Vécsei, L; Zádori, D	1
Debelius, JW; Factor, SA; Hill-Burns, EM; Knight, R; Lewis, MR; Molho, E; Morton, JT; Payami, H; Peddada, SD; Wallen, ZD; Wissemann, WT; Zabetian, CP	1
Evans, AH; Fung, VSC; Hayes, M; Iansek, R; Kimber, T; O'Sullivan, JD; Sue, CM; Williams, DR	1
Chatamra, K; Dutta, S; Locke, C; Othman, AA; Rosebraugh, M	1
Buhmann, C; Hilker, R; Lingor, P; Reichmann, H; Schrader, C; Schwarz, J; Wolz, M	1
Gupta, S; Mittur, A; Modi, NB	1
Antonini, A; Cossu, G; Mancini, F; Modugno, N; Pilleri, M; Quatrale, R; Sensi, M; Tamma, F; Zibetti, M	1
Artusi, CA; Comi, C; Duker, AP; Espay, AJ; Lanotte, M; Lopiano, L; Maule, S; Merola, A; Romagnolo, A; Rosso, M; Zibetti, M	1
Aquilonius, SM; Nyholm, D	1
Albo, J; Hellström, M; Nyholm, D; Senek, M; Svenningsson, P	1
Doan, JB; Melvin, KG; Suchowersky, O; Whishaw, IQ	1
Addy, C; Assaid, C; Ellenbogen, A; Gottesdiener, K; Herring, WJ; Hreniuk, D; Jinnah, HA; Kirby, L; Leibowitz, MT; Stewart, RM; Stoch, SA; Stroh, M; Tarsy, D; Tetrud, J; Wagner, J; Xu, Y	1
Jurjevic, A; Kovacevic, M; Ljubicic, D; Mrsic-Pelcic, J; Perkovic, O; Rudez, J; Vitezic, D; Vitezic, M	1
Adamiak, U; Bialecka, M; Gawronska-Szklarz, B; Kaldonska, M; Klodowska-Duda, G; Safranow, K; Wyska, E	1
Eggert, K; Eichhorn, T; Oertel, WH; Ries, V; Selzer, R	1
Cetas, JS; Fields, JD	1
Deuschl, G; Herzog, J; Volkmann, J; Wailke, S; Witt, K	1
Bugalho, P; Lampreia, T; Santos, L; Soares, P	1
Gradl, B; Persson, U; Willis, M; Zoellner, Y	1
Ferreira, JJ; Sampaio, C	1
Fernandez, HH; Odin, P	1
Bengel, G; Ebersbach, G; Ehret, R; Jugel, C; Klostermann, F; Muhlack, S; Müller, T	1
Angrisano, S; Lanotte, M; Lopiano, L; Merola, A; Rizzi, L; Zibetti, M	1
Muhlack, S; Müller, T; Woitalla, D	1
Hazan, D; Siegert, S; Szyper-Kravitz, M	1
Chen, C; Cowles, VE; Illarioshkin, SN; Stolyarov, ID; Sweeney, M	1
Belcastro, V; Calabresi, P; Castrioto, A; Gallina, A; Rossi, A; Tambasco, N	1
Agarwal, P; Alcalay, R; Black, KJ; Chou, KL; Cote, L; Dayalu, P; Frank, S; Friedman, JH; Hartlein, J; Hauser, RA; Lang, AE; Marsh, L; Marshall, F; Moskowitz, C; Ravina, B; Riley, D; Sanchez-Ramos, J; Simon, DK; Simuni, T; Sutton, J; Tuite, P; Weintraub, D; Zesiewicz, T	1
Bel'gusheva, ME; Fedorova, NV; Iablonskaia, AIu	1
Adam, JJ; Duits, A; Scholtissen, B; van Houdt, H; Visser-Vandewalle, V; Winogrodzka, A	1
Ellenbogen, AL; Gupta, SK; Hauser, RA; Hsu, A; Kell, SH; Metman, LV; Modi, NB; O'Connell, MJ; Yao, HM	1
Babiuc, RD; Bajenaru, OA; Ene, A; Negreanu, L; Popescu, BO; Smarandache, GC	1
Buttarelli, FR; Campanelli, D; Fanciulli, A; Misasi, R; Pontieri, FR	1
Becker, N; Munhoz, RP; Teive, HA	1
Okun, MS	1
Grice, T; Stagg, P	1
Boskovic, R; Clark, M; Houle, S; Kish, SJ; Meyer, JH; Rabiner, EA; Rusjan, P; Sacher, J; Soliman, A; Wilson, AA	1
Askmark, H; Munro Neville, A; Nyholm, D; Parsons, RW	1
Añón, MJ; de la Fuente-Fernández, R; Fuster-Sanjurjo, L; Santos-García, D	1
Hauser, RA	1
Benko, R; Jain, L; Safranek, S	1
Coon, EA; Laughlin, RS	1
Johansson, A; Klangemo, K; Nyholm, D	1
Bhatia, KP; Dayan, P; Dolan, RJ; Hill, C; Seymour, B; Shiner, T; Wunderlich, K	1
Bini, V; Bortolato, M; Cannas, A; Marrosu, F; Puligheddu, M; Solla, P	1
Nishijima, K; Saito, S; Shioda, K	1
Muhlack, S; Müller, T	1
Dizdar, N; Hauge, T; Holmberg, B; Jansson, R; Johansson, A; Linder, J; Nyholm, D; Pålhagen, SE; Sydow, O; Wainwright, M; Widner, H	1
Belavic, J	1
Artusi, CA; De Angelis, C; Lopiano, L; Marchisio, A; Merola, A; Montanaro, E; Reggio, D; Ricchi, V; Rizzi, L; Rizzone, M; Zibetti, M	1
Müller, T; Skodda, S	1
Nyholm, D	1
Foote, KD; Hassan, A; Iyer, S; McFarland, NR; Okun, MS; Rodriguez, RL; Sriram, A; Ward, HE	1
Bömelburg, M; Ebersbach, G; Jugel, C; Klostermann, F; Marzinzik, F; Müller, T	1
Chatamra, K; Dutta, S; Johansson, A; Locke, C; Nyholm, D; Odin, P; Othman, AA	1
Anderson, LC; Fagerlund, K; Gurvich, O	1
Datieva, VK; Levin, OS; Makotrova, TA	1
Benesh, J; Chatamra, K; Espay, AJ; Fernandez, HH; Hass, SL; Hauser, RA; Lenz, RA; Odin, P; Pritchett, Y; Standaert, DG; Vanagunas, A	1
Arai, M	1
Ghika, J; Solida, A; Vingerhoets, F	1
Kapustina, MT; Karaban', IN; Karasevich, NV; Lukhanina, EP	1
Borra, S; Hauser, RA; Zesiewicz, TA	1
Eng, JJ; Inkster, LM; MacIntyre, DL; Stoessl, AJ	1
Blomgren, M; Goberman, AM	1
Bakay, RA; Barnhart, H; Chockkan, V; DeLong, MR; Evatt, M; Freeman, A; Green, J; Haber, M; McDonald, W; Mewes, K; Triche, S; Vitek, JL; Wahlay, N; Zhang, JY	1
Decker, PA; Dousa, MK; Muenter, MD; Offord, KP; Tyce, GM; Weinshilboum, RM	1
Chaná, P; Fierro, A; Reyes-Parada, M; Sáez-Briones, P	1
Krahn, M; Lang, A; Marras, C; Naglie, G; Tomlinson, G	1
Hurka, MR; Leopold, NA; Polansky, M	1
Burkhard, PR; Flachsbart, KD; Fross, RD; Horvath, J; Kleiner-Fisman, G; Lang, AE; Lerch, R; Liaudat, S; Pache, JC; Rakowski, H; Raskoff, WJ; Stalder, H	1
Bara-Jimenez, W; Chase, TN; Dimitrova, T; Favit, A; Mouradian, MM; Sherzai, A	1
Delville, Y; Fleming, SM; Schallert, T	1
Antenor, JA; Kotagal, V; McGee-Minnich, L; Moerlein, SM; Perlmutter, JS; Racette, BA; Videen, TO	1
Arthur, K; Foley, SR; Kelly, BD	1
Bremen, D; Erdmann, C; Muhlack, S; Müller, T; Przuntek, H; Woitalla, D	1
Cercy, SP; Walker, RH; Warwick, R	1
Chigir', IP; Fedorova, NV	1
Ludin, HP; Surber, Ch	1
Chou, KL; Stacy, MA	1
Marsden, CD; Parkes, JD; Quinn, N	1
Bergmann, KJ; Clough, CG; Yahr, MD	1
Iadgarov, IS	1
Hadjikonstantinou, M; Markianos, M	1
Bianchine, JR; Dippel, RL; Hutton, JT; Meyer, PG; Strahlendorf, HK	1
Calne, DB; Larsen, TA; LeWitt, P; Newman, R	1
Diamond, SG; Markham, CH	1
Gerdes, U; Lehmann, K; Ulm, G	1
Klawans, HL	1
Calne, DB; Chuang, LW; Eisler, T; Karoum, F; Klein, DF; Liebowitz, MR; Quitkin, FM; Wyatt, RJ	1
Caraceni, T; Cocchi, D; Giovannini, P; Martinez-Campos, A; Müller, EE; Novelli, A	1
Calne, DB; Eisler, T; Kaiser, DL; MacLeod, RM; Thorner, MO	1
Glantz, RH; Glatt, SL; Goetz, CG; Klawans, HL; Tanner, CM	1
Goldstein, M; Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Nelson, J; Neophytides, A; Walker, R	1
Boshes, B	1
Agnoli, A; Baldassarre, M; D'Urso, R; De Giorgio, G; Falaschi, P; Rocco, A; Ruggieri, S	1
Edwards, M	1
Glantz, R; Goetz, CG; Klawans, HL; Nausieda, PA; Weiner, WJ	1
Gilden, ER; Hansch, EC; Hirsch, SB; Potvin, AR; Potvin, JH; Syndulko, K; Tourtellotte, WW	1
Bushenbark, K; Esterlitz, J; Gauger, L; Hauser, RA; Hubble, J; Koller, W; Lilienfeld, D; Malapira, T; Olanow, CW	1
Heerschap, A; Hinshaw, DB; Holshouser, BA; Kolem, H; Komu, M; Masur, H; Möller, HE; Sonninen, P; Vermathen, P; Zijlmans, J	1
Iacono, RP; Lonser, RR; Yamada, S	1
Camicioli, R; Joseph, CL; McWhorter, K; Siple, J	1
Brannan, T; Yahr, MD	1
Linazasoro, G	1
Bennett, KM; Castiello, U	1
Caligiuri, MP	1
Mahler, ME; Scharre, DW	1
Chase, TN; Hoff, J; Metman, LV; Mouradian, MM	1
Achiron, A; Djaldetti, R; Melamed, E; Ziv, I	1
Calne, DB; Duvoisin, RC; Koller, WC	1
Fahn, S; Grimes, JD; Hurtig, H; Jankovic, J; Klawans, H; Kurlan, R; Muenter, M; Olanow, CW; Shoulson, I; Stern, M	1
Lang, AE; Mark, MH; Sage, JI; Zimmerman, TR	1
Breimer, DD; Roos, RA; Tijssen, MA; van der Velde, EA	1
Bergen, M; Fowler, SB	1
Fullerton, T	1
Bennett, JP; Schuh, LA	1
Horstink, MW; Jansen, EN; Roos, RA; Wolters, EC	2
Chase, TN; Dambrosia, JM; Peppe, A	1
Cote, L; Fahn, S; Greene, P	1
Baraldo, M; Benetello, P; Furlanut, M; Hassan, E; Zara, G	1
Busenbark, K; Hubble, JP; Huber, SJ; Koller, WC; Michalek, D; Pahwa, R	1
Bowes, SG; Charlett, A; Dobbs, RJ; Dobbs, SM; Nicholson, PW; O'Neill, CJ; Purkiss, A; Weller, C	1
Cashaw, JL	1
Artem'ev, DV; Damulin, IV; Iakhno, NN	1
Buhrfiend, C; Carvey, PM; Goetz, CG; Lipton, JW; Pappert, EJ; Stebbins, GT	1
Pfeiffer, RF	1
Revell, SP; Shulman, LM; von Graevenitz, KS	1
Bowes, SG; Charlett, A; Dobbs, RJ; Dobbs, SM; Hunt, WB; Kirollos, C; Kosik, R; Mozol, K; Nicholson, PW; O'Neill, CJ; Purkiss, AG; Weller, C	1
Koller, WC; Lyons, K; Marjama, J; McGuire, D; Pahwa, R; Silverstein, P; Ward, R; Zwiebel, F	1
Muilenburg, ND	1
Tesselaar, HJ; Wolters, EC	1
Block, G; Irr, J; Liss, C; Nibbelink, D; Reines, S	1
Dike, GL	1
Lanska, DJ	1
Amyot, D; Demong, C; Duff, J; Gray, P; Murphy, D; Watson, J; Wilson, W	1
Block, GA; Cyhan, G; Gancher, ST; Hammerstad, JP; Nutt, JG; Woodward, WR	1
Barbato, L; Berardelli, A; Bonamartini, A; Manfredi, M; Patsalos, PN; Ruggieri, S; Stocchi, F	1
Sandyk, R	2
Chase, TN; Lenz, FA; van den Munckhof, P	1
Alberts, JL; Stelmach, GE; Tresilian, JR	1
Goetz, CG	1
Koller, WC; Wasielewski, PG	1
Grandas, F; Linazasoro, G; Martínez-Martín, P	1
Capildeo, R	1
Ruggieri, S; Silver, DE	1
Carter, JH; Nutt, JG; Thulin, PC; Woodward, WR	1
Hempel, AG; Maaty, MA; Sage, JI; Wagner, ML	1
Avraham, M; Dabby, R; Djaldetti, R; Melamed, E; Ziv, I; Zoldan, J	1
Jorga, KM; Nicholl, DJ	1
Scheife, RT	1
Ahlskog, JE; Burnett, OL; Maraganore, DM; Matsumoto, JY; O'Connor, MK; Stark, KF; Turk, MF; Uitti, RJ	1
Brousolle, E; Dentresangle, C; Froment, JC; Guerin, J; Lavenne, F; Le Bars, D; Pierre, C; Pollak, P; Veyre, L	1
Bennett, KM; Bonfiglioli, C; Castiello, U; Peppard, RF	1
Minagar, A; Shulman, LM; Weiner, WJ	1
Brooks, DJ; Gordin, A; Karlsson, M; Korpela, K; Pavese, N; Piccini, P	1
Mark, LP; Mueller, WR; Prieto, TE; Reynolds, NC; Terry, LC	1
Bilbao Garay, J; Castilla Castellano, V; Dhimes Tejada, P; Mesa Plaza, N	1
Bell, RD; Boyar, RM; Carruth, A; Rosenberg, RN	1
Diamond, SG; Markham, CH; Treciokas, LJ	2
Lieberman, A	1
Bowes, SG; Charlett, A; Dobbs, RJ; Dobbs, SM; Henley, M; Nicholson, PW; O'Neill, CJ; Purkiss, AG; Weller, C	1
Collin, C; Eckernäs, SA; Grahnén, A; Ling-Andersson, A; Nilsson, M; Tiger, G	1
Fenton, ML; Harnett, DS; Rosenthal, SH	1
Hildebrand, J; Moussa, Z; Przedborski, S; Raftopoulos, C	1
Caligiuri, MP; Heindel, WC; Lohr, JB	1
Anderson, TJ; Donaldson, IM; Ewer, TC; Gilchrist, NL	1
Rodnitzky, RL	1
Marsden, CD; Pires, M; Quinn, NP; Scaravilli, F; Steiger, MJ	1
Kleedorfer, B; Poewe, W	1
Ahlskog, JE; Bailey, PA; Muenter, MD; Stevens, PM	1
Cutlip, WD; Makela, EH	1
Karstaedt, PJ; Pincus, JH	1
Mark, MH; Sage, JI	2
Hutton, JT; Morris, JL	1
Jiménez, F; Jurado, J; Olvera, J; Rodríguez Cuevas, H; Velasco, F; Velasco, M	1
Fritz, VU; Ming, A; Temlett, JA	1
Findley, L; Prasher, D	1
Jacobs, MB; Varon, J	1
Cedarbaum, JM; Green-Parsons, A; Toy, LH	1
Cedarbaum, JM; Olanow, CW	1
Bulling, MT; Burns, RJ; Wing, LM	1
Cedarbaum, JM; Clark, M; Green-Parsons, A; Toy, LH	1
Glaeske, CS; Hofman, R; Pfeiffer, RF; Wilken, KE	1
Marsden, CD; Quinn, NP; Steiger, MJ; Toone, B	1
Coughlin, SS; Karstaedt, PJ; Pincus, JH	1
Block, G; Bush, D; Last, B; Liss, C; Manyam, B; Nakano, K; Nausieda, P; Olanow, CW; Tetrud, JA	1
Hodges, LC; Rapp, CG	1
Appley, AJ; Apuzzo, ML; Boyd, SD; Couldwell, WT; Neal, JH; Waters, CH; Weiner, LP; Wheelock, VH	1
Cowan, A	1
Cedarbaum, JM; Clark, M; Green-Parsons, A; Harts, A; McDowell, FH; Silvestri, M; Toy, L	1
Bovingdon, M; Frankel, JP; Kempster, PA; Lees, AJ; Pirtosek, Z; Stern, GM; Webster, R	1
Meltzer, HY; Parsa, MA; Ramirez, LF; Rohr, T	1
Campbell, NR; Goodridge, AE; Hasinoff, BB; Kara, M; Rankine, D	1
Berchou, RC; Galloway, MP; Kareti, D; LeWitt, PA; Nelson, MV	1
Boyson, SJ	1
Berger, HJ; Horstink, MW; Pasman, JW; van't Hof, MA; Zijlmans, JC	1
Baumann, G; Chin, L; Gopinathan, G; Lieberman, A; Miller, E; Neophytides, A	1
Duvoisin, RC; Heikkila, RE; McHale, DM; Sage, JI; Sonsalla, PK	1
Frankel, JP; Hughes, A; Lees, AJ; Stern, GM	1
Calne, DB; Calne, S; Douglas, J; Postnikoff, D; Poulin, K; Ross, S; Tsui, JK; Woodward, W	1
Elizan, TS; Moros, D; Yahr, MD	1
Chase, TN; Cox, C; Fabbrini, G; Fedio, P; Mohr, E; Schlegel, J; Williams, J	1
Deleu, D; Ebinger, G; Jacques, M; Michotte, Y	2
Gauger, LL; Olanow, CW; Werner, EG	1
Cedarbaum, JM; Kutt, H; McDowell, FH	2
Gilley, DW; Goetz, CG; Klawans, HL; Tanner, CM	1
Aymard, N; Rondot, P; Teinturier, A; Ziegler, M	1
Rinne, JO; Rinne, UK	1
Aarli, JA; Gilhus, NE	1
Gerdes, U; Haagen, K; Ulm, G	1
Dickins, QS; Dobson, J; Rodnitzky, RL	1
Cedarbaum, JM; Hoey, M; McDowell, FH	1
Ahlskog, JE; Bell, GN; Carmichael, SW; Kelly, PJ; Stoddard, SL; van Heerden, JA	1
Cedarbaum, JM	1
Jankovic, J; Schwartz, K; Vander Linden, C	1
Bush, DF; Liss, CL; Morton, A	1
August, TF; Bush, DF; Lasseter, KC; Musson, DG; Schwartz, S; Smith, ME; Titus, DC; Yeh, KC	1
Berchou, RC; Galloway, MP; Kareti, D; Kesaree, N; LeWitt, PA; Nelson, MV; Schlick, P	2
Bush, DF; Hutton, JT; Liss, CL; Morris, JL; Reines, S; Smith, ME	1
Baronti, F; Chase, TN; Fabbrini, G; Heuser, IJ; Juncos, JL; Mouradian, MM	1
Feldman, RG; Kelly, MR; Mosbach, PA; Saint Hilaire, MH; Thomas, CA	1
Reynolds, CM; Riklan, M; Stellar, S	1
Factor, SA; Ingenito, AM; Sanchez-Ramos, JR; Weiner, WJ	1
Ingvarsson, PE; Johnels, B; Steg, G; Thorselius, M; Valls, M	1
Friedman, JH; Lannon, MC	1
Critchley, P; Grandas Perez, FJ; Jenner, PG; Marsden, CD; Nomoto, M; Parkes, JD; Quinn, NP; Stahl, S	1
Koller, WC; Lang, AE; Marsden, CD; Quinn, NP	1
Cummings, JL; Friedenberg, DL	1
Huber, SJ; Paulson, GW; Shulman, HG; Shuttleworth, EC	1
Bratton, M; Jost, MG; Lannon, MC; Lockhart-Pretti, P; Thomas, CA	1
Jankovic, J	1
Ahlskog, JE; Bailey, PA; Bell, GN; McManis, PG; Muenter, MD	1
Birkmayer, W	1
Carroll, VS; Carvey, PM; Gilley, D; Goetz, CG; Klawans, HL; Shannon, KM; Tanner, CM	1
Bouchard, S; Gawel, MJ; Libman, I; Riopelle, RJ	1
Berger, J; Factor, SA; Sanchez-Ramos, J; Weiner, WJ	1
Como, P; Kurlan, R	1
Cedarbaum, JM; Hoey, M; Kutt, H; McDowell, FH	1
Elias, JW; Hutton, JT; Imke, SC; Morris, JL; Román, GC	1
Carruthers, M; Quinn, N	1
Bukhanov, VP	1
Brown, RG; Gotham, AM; Marsden, CD; Nissenbaum, H; Quinn, NP; Toone, B	1
Janota, I; Marsden, CD; Parkes, D; Quinn, N	1
Bouchard, S; Gawel, M; Libman, I; Riopelle, R	1
Jankovic, J; Orman, J	1
Alberts, MJ; Olanow, CW	1
Chase, TN; Fabbrini, G; Juncos, JL; Kask, AM; Mouradian, MM; Serrati, C	1
Clough, CG	1
Carroll, VS; Goetz, CG; Klawans, HL; Shannon, KM; Tanner, CM	2
Corbin, DO; Williams, AC	1
Chase, TN; Fabbrini, G; Juncos, JL; Mouradian, MM	1
Breck, L; Cedarbaum, JM; Kutt, H; McDowell, FH	2
Bozek, CB; Calne, DB; Calne, S; Purves, S; Suchowersky, O	1
Muenter, MD	1
Wilson, JA	1
Carter, JH; Nutt, JG; Woodward, WR	1
Doe, J	1
van der Drift, JH	1
Ballard, PA; Langston, JW; Tetrud, JW	1
Koller, WC	1
Di Battista, G; Di Meo, L; Figà-Talamanca, L; Gualandi, C; Lo Russo, F; Neri, G	1
Askenasy, JJ; Yahr, MD	1
Calne, DB; Jaffe, M; Larsen, TA; LeWitt, PA; Newman, RP	1
Zhou, XD	1
Yu, HZ	1

Reviews

57 review(s) available for carbidopa, levodopa drug combination and Parkinson Disease

Article	Year
The Use of Liquid Sinemet in Routine Clinical Practice of Advanced Parkinson's Disease: A Comparison of Available Options. Journal of Parkinson's disease, 2023, Volume: 13, Issue:4 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Levodopa; Parkinson Disease; Postural Balance; Time and Motion Studies	2023
Percutaneous Endoscopic Gastrostomy with Jejunal Extension Tube for the Delivery of Levodopa Carbidopa Intestinal Gel: Clinical Practice Guidelines of the Romanian Society of Digestive Endoscopy. Journal of gastrointestinal and liver diseases : JGLD, 2019, Sep-01, Volume: 28, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Consensus; Drug Administration Routes; Drug Combinations; Drug Compounding; Endoscopy, Gastrointestinal; Equipment Design; Gastrostomy; Gels; Humans; Infusion Pumps; Jejunum; Levodopa; Parkinson Disease; Treatment Outcome	2019
Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson's Disease. Drugs, 2019, Volume: 79, Issue:15 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Levodopa; Parkinson Disease	2019
A systematic review on the clinical experience with melevodopa/carbidopa fixed combination in patients with Parkinson disease. Minerva medica, 2019, Volume: 110, Issue:6 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Levodopa; Parkinson Disease	2019
Diagnosis and Treatment of Parkinson Disease: A Review. JAMA, 2020, 02-11, Volume: 323, Issue:6 Topics: Antiparkinson Agents; Carbidopa; Combined Modality Therapy; Deep Brain Stimulation; Diagnosis, Differential; Disease Progression; Dopamine Agonists; Drug Combinations; Humans; Levodopa; Parkinson Disease; Prognosis	2020
The Advantages of Levodopa-Carbidopa Intestinal Gel for Patients with Advanced Parkinson's Disease: A Systematic Review. Drug design, development and therapy, 2020, Volume: 14 Topics: Administration, Oral; Antiparkinson Agents; Carbidopa; Drug Combinations; Gels; Humans; Levodopa; Parkinson Disease	2020
Levodopa Inhalation Powder: A Review in Parkinson's Disease. Drugs, 2020, Volume: 80, Issue:8 Topics: Administration, Inhalation; Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Levodopa; Parkinson Disease; Powders	2020
The Choice Between Advanced Therapies for Parkinson's Disease Patients: Why, What, and When? Journal of Parkinson's disease, 2020, Volume: 10, Issue:s1 Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Clinical Decision-Making; Deep Brain Stimulation; Dopamine Agents; Drug Combinations; Humans; Infusions, Subcutaneous; Levodopa; Parkinson Disease	2020
On demand therapy for Parkinson's disease patients: Opportunities and choices. Postgraduate medicine, 2021, Volume: 133, Issue:7 Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Dopamine Agonists; Drug Administration Routes; Drug Combinations; Humans; Levodopa; Parkinson Disease	2021
Infusional Therapies, Continuous Dopaminergic Stimulation, and Nonmotor Symptoms. International review of neurobiology, 2017, Volume: 134 Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Dopamine; Dopamine Agents; Dopamine Agonists; Drug Combinations; Humans; Infusion Pumps, Implantable; Infusions, Intravenous; Infusions, Subcutaneous; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic	2017
Using tube feeding and levodopa-carbidopa intestinal gel application in advanced Parkinson's disease. British journal of nursing (Mark Allen Publishing), 2018, Mar-08, Volume: 27, Issue:5 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Enteral Nutrition; Female; Gels; Humans; Intestines; Levodopa; Male; Parkinson Disease; Quality of Life	2018
Levodopa-carbidopa intestinal gel: 'dismantling the road blocks of a journey'. Internal medicine journal, 2018, Volume: 48, Issue:4 Topics: Administration, Intranasal; Antiparkinson Agents; Carbidopa; Drug Combinations; Gastrostomy; Humans; Jejunostomy; Jejunum; Levodopa; Parkinson Disease; Patient Compliance	2018
Adjunctive Therapies in Parkinson's Disease: How to Choose the Best Treatment Strategy Approach. Drugs & aging, 2018, Volume: 35, Issue:12 Topics: Algorithms; Antiparkinson Agents; Carbidopa; Combined Modality Therapy; Deep Brain Stimulation; Drug Combinations; Humans; Levodopa; Parkinson Disease	2018
Apomorphine in the treatment of Parkinson's disease: a review. Arquivos de neuro-psiquiatria, 2018, Volume: 76, Issue:12 Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Deep Brain Stimulation; Dopamine Agonists; Drug Combinations; Humans; Levodopa; Parkinson Disease	2018
Contemporary Options for the Management of Motor Complications in Parkinson's Disease: Updated Clinical Review. Drugs, 2019, Volume: 79, Issue:6 Topics: Antiparkinson Agents; Basal Ganglia; Carbidopa; Dopamine Agonists; Drug Carriers; Drug Combinations; Drug Compounding; Drug Liberation; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Signal Transduction	2019
Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson's Disease in the United States. Advances in therapy, 2019, Volume: 36, Issue:9 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Observational Studies as Topic; Parkinson Disease; Precision Medicine; Prospective Studies; United States	2019
Parkinson Disease. Continuum (Minneapolis, Minn.), 2019, Volume: 25, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Exercise; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Therapies, Investigational	2019
Treatment of Parkinson's disease in the advanced stage. Journal of neural transmission (Vienna, Austria : 1996), 2013, Volume: 120, Issue:4 Topics: Antiparkinson Agents; Carbidopa; Dopamine Agonists; Drug Combinations; Dyskinesias; Humans; Levodopa; Parkinson Disease	2013
When the going gets tough: how to select patients with Parkinson's disease for advanced therapies. Practical neurology, 2013, Volume: 13, Issue:3 Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Deep Brain Stimulation; Drug Combinations; Drug Delivery Systems; Humans; Levodopa; Parkinson Disease; Patient Selection	2013
[Pharmacotherapy of Parkinson's disease: progress or regress?]. Postepy higieny i medycyny doswiadczalnej (Online), 2013, Jul-24, Volume: 67 Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Carbidopa; Corpus Striatum; Dopamine; Dopamine Antagonists; Drug Combinations; Humans; Levodopa; Parkinson Disease; Substantia Nigra	2013
[The treatment of Parkinson's disease]. Praxis, 2013, Dec-11, Volume: 102, Issue:25 Topics: Antiparkinson Agents; Carbidopa; Catechol O-Methyltransferase Inhibitors; Combined Modality Therapy; Deep Brain Stimulation; Dopamine Agonists; Drug Combinations; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neurologic Examination; Parkinson Disease; Physical Therapy Modalities	2013
Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls. Mayo Clinic proceedings, 2014, Volume: 89, Issue:7 Topics: Amantadine; Antiparkinson Agents; Carbidopa; Catechols; Dopamine Agonists; Drug Administration Schedule; Drug Combinations; Hospitalization; Humans; Levodopa; Monoamine Oxidase Inhibitors; Nitriles; Nursing Care; Parkinson Disease	2014
IPX066 , a mixed immediate/sustained-release levodopa preparation for Parkinson's disease. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:14 Topics: Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Humans; Levodopa; Parkinson Disease; Time Factors	2014
Novel formulations and modes of delivery of levodopa. Movement disorders : official journal of the Movement Disorder Society, 2015, Volume: 30, Issue:1 Topics: Animals; Antiparkinson Agents; Carbidopa; Drug Combinations; Drug Delivery Systems; Humans; Levodopa; Parkinson Disease	2015
Safety of IPX066 , an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's disease. Expert opinion on drug safety, 2015, Volume: 14, Issue:5 Topics: Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Dyskinesia, Drug-Induced; Half-Life; Humans; Levodopa; Parkinson Disease	2015
Approach to the patient with Parkinson disease. Primary care, 2015, Volume: 42, Issue:2 Topics: Antiparkinson Agents; Carbidopa; Deep Brain Stimulation; Diagnosis, Differential; Drug Combinations; Humans; Levodopa; Parkinson Disease; Primary Health Care; Risk Factors	2015
Current treatment and future prospects of dopa-induced dyskinesias. Drugs of today (Barcelona, Spain : 1998), 2015, Volume: 51, Issue:5 Topics: Amantadine; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Practice Guidelines as Topic; Treatment Outcome	2015
[Current possibilities of quality of life improvement in the late stages of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2015, Volume: 115, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Dopamine Agents; Drug Combinations; Gels; Humans; Levodopa; Parkinson Disease; Quality of Life; Severity of Illness Index; Treatment Outcome	2015
Duopa--a carbidopa/levodopa enteral suspension for Parkinson's disease. The Medical letter on drugs and therapeutics, 2015, Aug-03, Volume: 57, Issue:1474 Topics: Antiparkinson Agents; Carbidopa; Chemistry, Pharmaceutical; Drug Administration Routes; Drug Combinations; Drug Costs; Humans; Levodopa; Motor Activity; Parkinson Disease; Treatment Outcome	2015
Carbidopa/Levodopa ER Capsules (Rytary(®), Numient™): A Review in Parkinson's Disease. CNS drugs, 2016, Volume: 30, Issue:1 Topics: Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Drug Interactions; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic; Treatment Outcome	2016
Movement disorders: advances in 2015. The Lancet. Neurology, 2016, Volume: 15, Issue:1 Topics: Animals; Antiparkinson Agents; Carbidopa; DNA-Binding Proteins; Drug Combinations; Humans; Levodopa; Mitochondrial Proteins; Movement Disorders; Parkinson Disease; Transcription Factors	2016
Advances in levodopa therapy for Parkinson disease: Review of RYTARY (carbidopa and levodopa) clinical efficacy and safety. Neurology, 2016, Apr-05, Volume: 86, Issue:14 Suppl 1 Topics: Administration, Oral; Animals; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Administration Schedule; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Treatment Outcome	2016
Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review. CNS drugs, 2016, Volume: 30, Issue:5 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Levodopa; Parkinson Disease; Quality of Life	2016
An update on the diagnosis and treatment of Parkinson disease. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2016, Nov-01, Volume: 188, Issue:16 Topics: Age of Onset; Antiparkinson Agents; Carbidopa; Deep Brain Stimulation; Drug Combinations; Dyskinesias; Humans; Levodopa; Life Expectancy; Parkinson Disease; Practice Guidelines as Topic; Risk Assessment	2016
Continuous dopaminergic stimulation therapy for Parkinson's disease - recent advances. Current opinion in neurology, 2016, Volume: 29, Issue:4 Topics: Administration, Cutaneous; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Gels; Humans; Levodopa; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes	2016
Comment on: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review". CNS drugs, 2016, Volume: 30, Issue:10 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Gels; Intestines; Levodopa; Parkinson Disease	2016
Novel Levodopa Formulations for Parkinson's Disease. CNS drugs, 2016, Volume: 30, Issue:11 Topics: Antiparkinson Agents; Carbidopa; Catechols; Chemistry, Pharmaceutical; Drug Combinations; Humans; Levodopa; Nitriles; Parkinson Disease	2016
The need for non-oral therapy in Parkinson's disease; a potential role for apomorphine. Parkinsonism & related disorders, 2016, Volume: 33 Suppl 1 Topics: Animals; Antiparkinson Agents; Apomorphine; Carbidopa; Drug Administration Routes; Drug Combinations; Gels; Humans; Intestines; Levodopa; Parkinson Disease	2016
Practical approaches to commencing device-assisted therapies for Parkinson disease in Australia. Internal medicine journal, 2017, Volume: 47, Issue:10 Topics: Antiparkinson Agents; Apomorphine; Australia; Carbidopa; Deep Brain Stimulation; Drug Combinations; Humans; Infusions, Parenteral; Infusions, Subcutaneous; Levodopa; Parkinson Disease	2017
Pharmacokinetics of Rytary Clinical pharmacokinetics, 2017, Volume: 56, Issue:9 Topics: Animals; Antiparkinson Agents; Capsules; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Drug Compounding; Humans; Levodopa; Parkinson Disease	2017
Development of new levodopa treatment strategies in Parkinson's disease-from bedside to bench to bedside. Upsala journal of medical sciences, 2017, Volume: 122, Issue:2 Topics: Animals; Carbidopa; Central Nervous System; Drug Approval; Drug Combinations; Drug Delivery Systems; Drug Design; European Union; Gels; History, 20th Century; History, 21st Century; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic; Tablets	2017
Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease. Current medical research and opinion, 2011, Volume: 27, Issue:5 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Levodopa; MEDLINE; Parkinson Disease; Randomized Controlled Trials as Topic	2011
Treatment of advanced Parkinson's disease with levodopa/carbidopa intestinal gel is associated with improvements in Hoehn and Yahr stage. Parkinsonism & related disorders, 2012, Volume: 18, Issue:5 Topics: Antiparkinson Agents; Carbidopa; Cross-Over Studies; Drug Combinations; Female; Gels; Humans; Levodopa; Male; Outcome Assessment, Health Care; Parkinson Disease; Randomized Controlled Trials as Topic; Severity of Illness Index	2012
IPX066: a novel carbidopa-levodopa extended-release formulation. Expert review of neurotherapeutics, 2012, Volume: 12, Issue:2 Topics: Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Parkinson Disease	2012
Clinical inquiry. Which drugs work best for early Parkinson's disease? The Journal of family practice, 2012, Volume: 61, Issue:2 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Family Practice; Humans; Indoles; Levodopa; Motor Skills; Neurologic Examination; Parkinson Disease	2012
Duodopa® treatment for advanced Parkinson's disease: a review of efficacy and safety. Parkinsonism & related disorders, 2012, Volume: 18, Issue:8 Topics: Animals; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Drug Combinations; Humans; Levodopa; Parkinson Disease; Quality of Life; Severity of Illness Index; Treatment Outcome	2012
[Prevention and treatment of fluctuations in patients with Parkinson's disease]. Praxis, 2006, Dec-20, Volume: 95, Issue:51-52 Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dopamine Agonists; Drug Administration Routes; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Infusion Pumps, Implantable; Levodopa; Monoamine Oxidase Inhibitors; Neurologic Examination; Parkinson Disease; Treatment Outcome	2006
Sinemet and the treatment of Parkinsonism. Annals of internal medicine, 1981, Volume: 94, Issue:3 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Chemical Phenomena; Chemistry; Drug Combinations; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Prognosis	1981
Treatment of Parkinson's disease. From theory to practice. Postgraduate medicine, 1994, Volume: 95, Issue:5 Topics: Aged; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Dopamine; Drug Combinations; Free Radicals; Humans; Levodopa; Oxygen; Parkinson Disease; Selegiline	1994
Initiating therapy for Parkinson's disease. Neurology, 1998, Volume: 50, Issue:6 Suppl 6 Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Carbidopa; Cholinergic Antagonists; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Selegiline	1998
Too many treatments for Parkinson's disease: how should they be used? WMJ : official publication of the State Medical Society of Wisconsin, 2000, Volume: 99, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Decision Making; Drug Combinations; Humans; Levodopa; Neurosurgical Procedures; Parkinson Disease; Stereotaxic Techniques	2000
[Serotonin syndrome: report of a fatal case and review of the literature]. Revista clinica espanola, 2002, Volume: 202, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Depressive Disorder, Major; Drug Combinations; Drug Synergism; Fatal Outcome; Fluoxetine; Humans; Levodopa; Male; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin Syndrome	2002
An integrated approach to patient management in Parkinson's disease. Neurologic clinics, 1992, Volume: 10, Issue:2 Topics: Activities of Daily Living; Antiparkinson Agents; Carbidopa; Dopamine Agents; Drug Combinations; Humans; Levodopa; Parkinson Disease; Selegiline	1992
Medical treatment of Parkinson's disease. Comprehensive therapy, 1989, Volume: 15, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease	1989
The promise and limitations of controlled-release oral levodopa administration. Clinical neuropharmacology, 1989, Volume: 12, Issue:3 Topics: Carbidopa; Delayed-Action Preparations; Drug Combinations; Humans; Levodopa; Parkinson Disease	1989
Rationale for continuous dopaminomimetic therapy of Parkinson's disease. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Levodopa; Parkinson Disease	1989
Parkinson's disease: recent advances in therapy. Southern medical journal, 1988, Volume: 81, Issue:8 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenal Medulla; Antiparkinson Agents; Carbidopa; Dopamine; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pyridines	1988

Trials

113 trial(s) available for carbidopa, levodopa drug combination and Parkinson Disease

Article	Year
Fasting state is one of the factors associated with plasma levodopa fluctuations during levodopa‒carbidopa intestinal gel treatment. Parkinsonism & related disorders, 2021, Volume: 91 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Eating; Fasting; Female; Gels; Humans; Intestines; Levodopa; Lunch; Male; Motor Activity; Parkinson Disease	2021
ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study. Parkinsonism & related disorders, 2021, Volume: 91 Topics: Administration, Oral; Aged; Antiparkinson Agents; Carbidopa; Catechols; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infusions, Subcutaneous; Levodopa; Male; Middle Aged; Motor Activity; Nitriles; Parkinson Disease; Proof of Concept Study; Treatment Outcome	2021
The effect of functional status impairment on nursing home admission risk among patients with advanced Parkinson's disease. Journal of medical economics, 2020, Volume: 23, Issue:3 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Double-Blind Method; Drug Combinations; Female; Gels; Homes for the Aged; Humans; Levodopa; Male; Medicare; Monte Carlo Method; Nursing Homes; Parkinson Disease; Physical Functional Performance; Severity of Illness Index; United States	2020
The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study. Journal of Parkinson's disease, 2020, Volume: 10, Issue:4 Topics: Aged; Carbidopa; Cross-Over Studies; Dopamine Agonists; Double-Blind Method; Drug Combinations; Feasibility Studies; Female; Humans; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D5; Severity of Illness Index	2020
Population pharmacokinetics of levodopa gel infusion in Parkinson's disease: effects of entacapone infusion and genetic polymorphism. Scientific reports, 2020, 10-22, Volume: 10, Issue:1 Topics: Carbidopa; Catechol O-Methyltransferase; Catechols; Cross-Over Studies; Dopa Decarboxylase; Double-Blind Method; Drug Combinations; Drug Delivery Systems; Female; Gels; Genotype; Humans; Levodopa; Male; Models, Biological; Nitriles; Parkinson Disease; Polymorphism, Genetic	2020
Continuous Subcutaneous Levodopa Delivery for Parkinson's Disease: A Randomized Study. Journal of Parkinson's disease, 2021, Volume: 11, Issue:1 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Feasibility Studies; Female; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Severity of Illness Index; Single-Blind Method	2021
Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®). Parkinsonism & related disorders, 2021, Volume: 82 Topics: Aged; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Time Factors	2021
Daily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot study. Parkinsonism & related disorders, 2018, Volume: 49 Topics: Aged; Antiparkinson Agents; Carbidopa; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Mucuna; Outcome Assessment, Health Care; Parkinson Disease; Phytotherapy; Pilot Projects; Plant Preparations; Seeds	2018
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Compulsive Behavior; Double-Blind Method; Drug Combinations; Female; Gels; Humans; International Cooperation; Intestines; Levodopa; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Polyneuropathies; Weight Loss	2018
A Transitional Probability Model for Parkinson's Disease Motor States With Applications to Missing Data. Therapeutic innovation & regulatory science, 2019, Volume: 53, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Double-Blind Method; Drug Combinations; Dyskinesias; Female; Humans; Levodopa; Male; Markov Chains; Middle Aged; Models, Statistical; Movement; Parkinson Disease	2019
Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial. Journal of neurology, neurosurgery, and psychiatry, 2019, Volume: 90, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Combinations; Drug Substitution; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole	2019
Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease. Parkinsonism & related disorders, 2019, Volume: 64 Topics: Administration, Inhalation; Aged; Antiparkinson Agents; Carbidopa; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2019
Pharmacokinetics and efficacy of a novel formulation of carbidopa-levodopa (Accordion Pill Parkinsonism & related disorders, 2019, Volume: 65 Topics: Aged; Antiparkinson Agents; Carbidopa; Cohort Studies; Cross-Over Studies; Drug Combinations; Drug Compounding; Drug Delivery Systems; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pilot Projects; Proof of Concept Study; Treatment Outcome	2019
Population pharmacodynamics of IPX066: an oral extended-release capsule formulation of carbidopa-levodopa, and immediate-release carbidopa-levodopa in patients with advanced Parkinson's disease. Journal of clinical pharmacology, 2013, Volume: 53, Issue:5 Topics: Antiparkinson Agents; Carbidopa; Cross-Over Studies; Delayed-Action Preparations; Drug Combinations; Dyskinesias; Female; Humans; Levodopa; Male; Models, Biological; Parkinson Disease	2013
Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial. The Lancet. Neurology, 2013, Volume: 12, Issue:4 Topics: Aged; Carbidopa; Chemistry, Pharmaceutical; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills Disorders; Parkinson Disease; Treatment Outcome	2013
Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease. Parkinsonism & related disorders, 2014, Volume: 20, Issue:2 Topics: Aged; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome	2014
Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:1 Topics: Antiparkinson Agents; Carbidopa; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prodrugs; Treatment Outcome	2014
Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients. Parkinsonism & related disorders, 2014, Volume: 20, Issue:12 Topics: Aged; Antiparkinson Agents; Carbidopa; Catechols; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Treatment Outcome; Walking	2014
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results. Movement disorders : official journal of the Movement Disorder Society, 2015, Volume: 30, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Severity of Illness Index; Treatment Outcome	2015
Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2015, Volume: 30, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Cross-Over Studies; Drug Combinations; Drug Delivery Systems; Female; Follow-Up Studies; Gastrointestinal Tract; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Time Factors; Treatment Outcome	2015
Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension Trial. CNS drugs, 2015, Volume: 29, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease; Severity of Illness Index	2015
Obstructive sleep apnea in Parkinson's disease patients: effect of Sinemet CR taken at bedtime. Sleep & breathing = Schlaf & Atmung, 2016, Volume: 20, Issue:1 Topics: Aged; Arousal; Carbidopa; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Sleep Apnea, Obstructive; Wakefulness	2016
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off. Journal of neural transmission (Vienna, Austria : 1996), 2015, Volume: 122, Issue:12 Topics: Antiparkinson Agents; Benserazide; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Data Interpretation, Statistical; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Retrospective Studies; Treatment Outcome	2015
Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson's Disease: Experience in Clinical Trials. Journal of Parkinson's disease, 2015, Volume: 5, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Catechols; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Nitriles; Outcome Assessment, Health Care; Parkinson Disease; Treatment Outcome	2015
Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease. Journal of clinical pharmacology, 2016, Volume: 56, Issue:8 Topics: Aged; Antiparkinson Agents; Capsules; Carbidopa; Cohort Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome	2016
Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients. Movement disorders : official journal of the Movement Disorder Society, 2016, Volume: 31, Issue:4 Topics: Administration, Mucosal; Aged; Antiparkinson Agents; Carbidopa; Double-Blind Method; Drug Combinations; Dyskinesia, Drug-Induced; Female; Gels; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome	2016
Levodopa increases oxidative stress and repulsive guidance molecule A levels: a pilot study in patients with Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2016, Volume: 123, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Chromatography, High Pressure Liquid; Cysteine; Dipeptides; Drug Combinations; Female; GPI-Linked Proteins; Humans; Levodopa; Male; Middle Aged; Nerve Tissue Proteins; Oxidative Stress; Parkinson Disease; Pilot Projects	2016
Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol-O-Methyltransferase Activity and Motor Response in Patients With Parkinson Disease. Clinical pharmacology in drug development, 2016, Volume: 5, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Oxadiazoles; Parkinson Disease	2016
Effect of Levodopa + Carbidopa on the Laryngeal Electromyographic Pattern in Parkinson Disease. Journal of voice : official journal of the Voice Foundation, 2017, Volume: 31, Issue:3 Topics: Aged; Antiparkinson Agents; Brazil; Carbidopa; Drug Administration Schedule; Drug Combinations; Electromyography; Female; Humans; Laryngeal Muscles; Levodopa; Male; Middle Aged; Parkinson Disease; Phonation; Predictive Value of Tests; Prospective Studies; Time Factors; Treatment Outcome; Voice Quality	2017
Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study. Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:2 Topics: Aged; Antiparkinson Agents; Carbidopa; Catechols; Cross-Over Studies; Drug Combinations; Female; Humans; Infusions, Parenteral; Levodopa; Male; Nitriles; Parkinson Disease; Treatment Outcome	2017
Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease. Journal of the neurological sciences, 2017, Feb-15, Volume: 373 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Administration Schedule; Drug Combinations; Drug Substitution; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Treatment Outcome	2017
Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa. Journal of Parkinson's disease, 2017, Volume: 7, Issue:2 Topics: Administration, Oral; Antiparkinson Agents; Carbidopa; Double-Blind Method; Drug Combinations; Drug Delivery Systems; Gels; Humans; Levodopa; Parkinson Disease	2017
Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms. Behavioural brain research, 2008, Dec-12, Volume: 194, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Disability Evaluation; Double-Blind Method; Drug Combinations; Feeding Behavior; Female; Follow-Up Studies; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Motor Skills Disorders; Parkinson Disease; Prospective Studies; Severity of Illness Index	2008
Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease. Journal of clinical pharmacology, 2009, Volume: 49, Issue:7 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Hypertension; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Piperidines; Pyrimidines; Receptors, N-Methyl-D-Aspartate	2009
Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease. Clinical neuropharmacology, 2010, Volume: 33, Issue:3 Topics: Age of Onset; Aged; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Drug Combinations; Drug Therapy, Combination; Dyskinesias; Enzyme Inhibitors; Female; Half-Life; Humans; Levodopa; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nitrophenols; Parkinson Disease; Severity of Illness Index; Tolcapone; Tyrosine	2010
Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to L-dopa in the treatment of Parkinson's disease: a randomized, multicenter, open-label, parallel-group study. Clinical neuropharmacology, 2010, Volume: 33, Issue:3 Topics: Aged; Ambulatory Care Facilities; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Dyskinesias; Enzyme Inhibitors; Feasibility Studies; Female; Humans; Levodopa; Male; Middle Aged; Nitrophenols; Parkinson Disease; Severity of Illness Index; Time Factors; Tolcapone; Treatment Outcome	2010
Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease. European journal of neurology, 2011, Volume: 18, Issue:4 Topics: Aged; Aged, 80 and over; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Sleep; Sleep Wake Disorders	2011
Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel. Journal of neural transmission (Vienna, Austria : 1996), 2011, Volume: 118, Issue:9 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Duodenum; Female; Gels; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Methyldopa; Middle Aged; Parkinson Disease	2011
Inhibition of catechol-O-methyltransferase modifies acute homocysteine rise during repeated levodopa application in patients with Parkinson's disease. Naunyn-Schmiedeberg's archives of pharmacology, 2011, Volume: 383, Issue:6 Topics: Aged; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Biological Availability; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Drug Combinations; Drug Therapy, Combination; Female; Half-Life; Homocysteine; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Tyrosine	2011
Pharmacokinetics of levodopa/carbidopa delivered from gastric-retentive extended-release formulations in patients with Parkinson's disease. Journal of clinical pharmacology, 2012, Volume: 52, Issue:7 Topics: Aged; Antiparkinson Agents; Area Under Curve; Carbidopa; Cross-Over Studies; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Models, Biological; Parkinson Disease; Tablets; Time Factors	2012
[Levodopa medications in the treatment of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2011, Volume: 111, Issue:5 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Drugs, Generic; Female; Humans; Levodopa; Male; Parkinson Disease; Severity of Illness Index; Treatment Outcome	2011
Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:12 Topics: Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Carbidopa; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Time Factors	2011
Dopaminergic drug-induced modulation of the expression of the dopamine transporter in peripheral blood lymphocytes in Parkinson's disease. Pharmacological reports : PR, 2011, Volume: 63, Issue:4 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Drug Combinations; Female; Flow Cytometry; Gene Expression Regulation; Humans; Indoles; Levodopa; Lymphocytes; Male; Middle Aged; Parkinson Disease; Pramipexole	2011
Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [(11)C]-harmine positron emission tomography study. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2012, Volume: 32, Issue:3 Topics: Carbidopa; Carbon Radioisotopes; Corpus Striatum; Dopamine; Dopamine Agonists; Drug Combinations; Harmine; Humans; Levodopa; Monoamine Oxidase; Parkinson Disease; Positron-Emission Tomography; Prefrontal Cortex; Protein Binding; Serotonin; Substrate Specificity; Time Factors; Tryptophan	2012
Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease. Brain : a journal of neurology, 2012, Volume: 135, Issue:Pt 6 Topics: Adult; Aged; Aged, 80 and over; Association Learning; Carbidopa; Choice Behavior; Dopamine Agents; Dose-Response Relationship, Drug; Drug Combinations; Female; Generalization, Psychological; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Nucleus Accumbens; Oxygen; Parkinson Disease; Photic Stimulation; Prefrontal Cortex; Psychomotor Performance; Reinforcement, Psychology	2012
Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease. Acta neurologica Scandinavica, 2012, Volume: 126, Issue:6 Topics: Antiparkinson Agents; Carbidopa; Drug Administration Routes; Drug Combinations; Female; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Treatment Outcome	2012
[The optimization of using levodopa in patients with Parkinson's disease: results of the OPTIMA study]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012, Volume: 112, Issue:10 Pt 2 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome	2012
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease open-label study: interim results. Parkinsonism & related disorders, 2013, Volume: 19, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Infusion Pumps; Jejunum; Levodopa; Male; Middle Aged; Parkinson Disease	2013
Ropinirole does not affect plasma arginine vasopressin levels in patients with advanced Parkinson's disease. Neuro endocrinology letters, 2012, Volume: 33, Issue:7 Topics: Aged; Arginine Vasopressin; Carbidopa; Catechols; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Humans; Inappropriate ADH Syndrome; Indoles; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease	2012
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Annals of neurology, 2003, Volume: 53, Issue:5 Topics: Antiparkinson Agents; Atrophy; Brain; Carbidopa; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Combinations; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Globus Pallidus; Humans; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Rigidity; Neurosurgical Procedures; Parkinson Disease; Severity of Illness Index; Treatment Outcome; Tremor	2003
[Pharmacokinetic comparison of Sinemet and Grifoparkin (levodopa/carbidopa 250/25 mg) in Parkinson s disease: a single dose study]. Revista medica de Chile, 2003, Volume: 131, Issue:6 Topics: Antiparkinson Agents; Biological Availability; Carbidopa; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2003
Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:1 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Double-Blind Method; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Pain Measurement; Parkinson Disease; Pramipexole; Quality of Life; Thiazoles	2004
Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:10 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pilot Projects; Pramipexole; Thiazoles	2004
Controlled-release carbidopa/levodopa in the treatment of Parkinsonism. Clinical neuropharmacology, 1984, Volume: 7, Issue:2 Topics: Aged; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1984
Prolactin secretion in Parkinson disease. Neurology, 1981, Volume: 31, Issue:10 Topics: Adult; Aged; Blood-Brain Barrier; Bromocriptine; Carbidopa; Dopamine; Drug Combinations; Female; Humans; Hypothalamus, Anterior; Levodopa; Male; Middle Aged; Parkinson Disease; Pituitary Gland; Placebos; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone	1981
Parkinson's disease: Cogentin with Sinemet, a better response. Progress in neuro-psychopharmacology & biological psychiatry, 1982, Volume: 6, Issue:1 Topics: Aged; Antiparkinson Agents; Benztropine; Carbidopa; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Tropanes	1982
The effect of deprenyl and levodopa on the progression of Parkinson's disease. Annals of neurology, 1995, Volume: 38, Issue:5 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Bromocriptine; Carbidopa; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Least-Squares Analysis; Levodopa; Male; Parkinson Disease; Prospective Studies; Selegiline; Statistics, Nonparametric; Treatment Outcome	1995
Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study. Magnetic resonance in medicine, 1995, Volume: 33, Issue:5 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiparkinson Agents; Aspartic Acid; Carbidopa; Choline; Corpus Striatum; Dopamine Agonists; Drug Combinations; Female; Humans; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Pilot Projects; Protons	1995
Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease. Annals of neurology, 1995, Volume: 37, Issue:1 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Selegiline; Treatment Outcome	1995
Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:4 Topics: Administration, Oral; Aged; Antiparkinson Agents; Biological Availability; Carbidopa; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Solutions; Tablets; Therapeutic Equivalency	1994
A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:1 Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Carbidopa; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Electrocardiography; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Motor Skills; Neurologic Examination; Parkinson Disease; Pergolide	1994
Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group. Advances in neurology, 1993, Volume: 60 Topics: Antiparkinson Agents; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Neurologic Examination; Parkinson Disease	1993
Defining small differences in efficacy between anti-parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor. British journal of clinical pharmacology, 1993, Volume: 35, Issue:4 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Benserazide; Carbidopa; Carboxy-Lyases; Delayed-Action Preparations; Drug Combinations; Female; Gait; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1993
[The use of the Sinemet-CR preparation in treating Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1995, Volume: 95, Issue:5 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Higher Nervous Activity; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1995
Objective measurement of activation of rigidity: diagnostic, pathogenetic and therapeutic implications in parkinsonism. British journal of clinical pharmacology, 1996, Volume: 41, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Hand Strength; Humans; Isometric Contraction; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Physical Exertion; Reproducibility of Results; Sensitivity and Specificity; Torque; Trihexyphenidyl	1996
Pharmacokinetic comparison of Sinemet and Atamet (generic carbidopa/levodopa): a single-dose study. Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:4 Topics: Administration, Oral; Aged; Antiparkinson Agents; Biological Availability; Carbidopa; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Metabolic Clearance Rate; Motor Skills; Neurologic Examination; Parkinson Disease; Therapeutic Equivalency	1996
International (NL-UK) double-blind study of Sinemet CR and standard Sinemet (25/100) in 170 patients with fluctuating Parkinson's disease. Journal of neurology, 1996, Volume: 243, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Humans; International Cooperation; Levodopa; Middle Aged; Parkinson Disease	1996
Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group. European neurology, 1997, Volume: 37, Issue:1 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1997
Controlled release levodopa/carbidopa 25/100 (Sinemet CR 25/100): pharmacokinetics and clinical efficacy in untreated parkinsonian patients. Clinical neuropharmacology, 1994, Volume: 17, Issue:5 Topics: Absorption; Antiparkinson Agents; Biological Availability; Carbidopa; Delayed-Action Preparations; Drug Combinations; Humans; Levodopa; Parkinson Disease	1994
Quality of life in patients with Parkinson's disease who transfer from standard levodopa to Sinemet CR: the STAR Study. The STAR Multicenter Study Group. Journal of neurology, 1998, Volume: 245 Suppl 1 Topics: Activities of Daily Living; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Humans; Levodopa; Parkinson Disease; Quality of Life; Treatment Outcome	1998
Implications of the 5-year CR FIRST trial. Sinemet CR Five-Year International Response Fluctuation Study. Neurology, 1998, Volume: 50, Issue:6 Suppl 6 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1998
Pharmacoeconomic analysis of using Sinemet CR over standard Sinemet in parkinsonian patients with motor fluctuations. The Annals of pharmacotherapy, 1998, Volume: 32, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Prospective Studies	1998
COMT inhibition with tolcapone does not affect carbidopa pharmacokinetics in parkinsonian patients in levodopa/carbidopa (Sinemet). British journal of clinical pharmacology, 1999, Volume: 48, Issue:3 Topics: Aged; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Female; Humans; Levodopa; Male; Middle Aged; Nitrophenols; Parkinson Disease; Tolcapone	1999
The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:6 Topics: Aged; Brain; Brain Mapping; Carbidopa; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Motor Skills; Nerve Tissue Proteins; Parkinson Disease; Pergolide; Putamen; Tomography, Emission-Computed, Single-Photon	1999
The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 2000, Volume: 68, Issue:5 Topics: Adult; Aged; Antiparkinson Agents; Biological Availability; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Enzyme Inhibitors; Female; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease	2000
A double-blind comparison of levodopa, Madopa, and Sinemet in Parkinson disease. Annals of neurology, 1978, Volume: 3, Issue:3 Topics: Adult; Benserazide; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting	1978
Clinical efficacy of Sinemet CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open, and a double-blind, double-dummy, multicenter treatment evaluation. The Dutch Sinemet CR Study Group. Clinical neurology and neurosurgery, 1992, Volume: 94, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Patient Satisfaction; Sleep Stages	1992
Objective evidence for tolerance, against a background of improvement, during maintenance therapy with controlled release levodopa/carbidopa. European journal of clinical pharmacology, 1992, Volume: 43, Issue:5 Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Gait; Humans; Levodopa; Middle Aged; Parkinson Disease; Tablets	1992
Comparative multiple-dose pharmacokinetics of controlled-release levodopa products. European neurology, 1992, Volume: 32, Issue:6 Topics: Adult; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Metabolic Clearance Rate; Methyldopa; Neurologic Examination; Parkinson Disease	1992
Trial of Sinemet CR4 in patients with Parkinson's disease. The New Zealand medical journal, 1992, Mar-11, Volume: 105, Issue:929 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease	1992
Comparative efficacy of two oral sustained-release preparations of L-dopa in fluctuating Parkinson's disease. Preliminary findings in 20 patients. Journal of neural transmission. Parkinson's disease and dementia section, 1992, Volume: 4, Issue:2 Topics: Benserazide; Carbidopa; Delayed-Action Preparations; Drug Combinations; Follow-Up Studies; Humans; Levodopa; Parkinson Disease	1992
Long-term evaluation of Sinemet CR in parkinsonian patients with motor fluctuations. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1991, Volume: 18, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Movement; Parkinson Disease; Time Factors	1991
L-deprenyl (selegiline) added to Sinemet CR in the management of Parkinson's disease patients with motor response fluctuations. Clinical neuropharmacology, 1991, Volume: 14, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Movement; Parkinson Disease; Selegiline; Time Factors	1991
Controlled release levodopa/carbidopa (Sinemet CR4) in Parkinson's disease--an open evaluation of efficacy and safety. Australian and New Zealand journal of medicine, 1991, Volume: 21, Issue:4 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1991
Sinemet CR in Parkinson's disease. The Nebraska medical journal, 1991, Volume: 76, Issue:1 Topics: Aged; Antiparkinson Agents; Carbidopa; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos	1991
Standard and controlled-release levodopa/carbidopa in patients with fluctuating Parkinson's disease on a protein redistribution diet. A preliminary report. Archives of neurology, 1991, Volume: 48, Issue:4 Topics: Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dietary Proteins; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Female; Humans; Levodopa; Male; Parkinson Disease	1991
An open multicenter trial of Sinemet CR in levodopa-naive Parkinson's disease patients. Clinical neuropharmacology, 1991, Volume: 14, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Drug Tolerance; Female; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease	1991
Results of long-term treatment with controlled-release levodopa/carbidopa (Sinemet CR). Journal of neural transmission. Parkinson's disease and dementia section, 1990, Volume: 2, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Middle Aged; Parkinson Disease; Prognosis; Statistics as Topic; Time Factors	1990
Diurnal differences in response to oral levodopa. Journal of neurology, neurosurgery, and psychiatry, 1990, Volume: 53, Issue:11 Topics: Administration, Oral; Aged; Antiparkinson Agents; Carbidopa; Circadian Rhythm; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease	1990
Randomized double-blind cross-over study of Sinemet-controlled release (CR4 50/200) versus Sinemet 25/100 in Parkinson's disease. European neurology, 1990, Volume: 30, Issue:2 Topics: Aged; Aged, 80 and over; Carbidopa; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1990
The effect of dietary protein on the efficacy of L-dopa: a double-blind study. Neurology, 1989, Volume: 39, Issue:4 Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Dietary Proteins; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation; Selegiline	1989
CV 205-502: safety, tolerance to, and efficacy of increasing doses in patients with Parkinson's disease in a double-blind, placebo crossover study. Clinical neuropharmacology, 1989, Volume: 12, Issue:6 Topics: Adult; Aged; Aminoquinolines; Antiparkinson Agents; Carbidopa; Dopamine Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1989
A double-blind crossover comparison of Sinemet CR4 and standard Sinemet 25/100 in patients with Parkinson's disease and fluctuating motor performance. Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:2 Topics: Carbidopa; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Humans; Levodopa; Middle Aged; Motor Skills; Parkinson Disease; Random Allocation	1989
Comparison of Sinemet CR4 and standard Sinemet: double blind and long-term open trial in parkinsonian patients with fluctuations. Movement disorders : official journal of the Movement Disorder Society, 1989, Volume: 4, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Humans; Levodopa; Middle Aged; Movement; Parkinson Disease; Randomized Controlled Trials as Topic	1989
An open multicenter long-term treatment evaluation of Sinemet CR. Sinemet CR Multicenter Study Group. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Multicenter Studies as Topic; Parkinson Disease; Random Allocation; Time Factors	1989
Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Biological Availability; Carbidopa; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Fasting; Half-Life; Humans; Intestinal Absorption; Levodopa; Middle Aged; Parkinson Disease; Random Allocation; Reference Values; Tablets; Tyrosine	1989
Controlled-release carbidopa/levodopa (Sinemet 50/200 CR4): clinical and pharmacokinetic studies. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Aged; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Humans; Levodopa; Middle Aged; Parkinson Disease; Random Allocation; Tyrosine	1989
Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's disease. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Movement Disorders; Multicenter Studies as Topic; Parkinson Disease; Randomized Controlled Trials as Topic	1989
Controlled-release carbidopa/levodopa (CR) in parkinsonian patients with response fluctuations on standard levodopa treatment: clinical and pharmacokinetic observations. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Aged; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation	1989
Double-blind comparison of standard Sinemet and Sinemet CR in patients with mild-to-moderate Parkinson's disease. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Aged; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation	1989
Controlled-release Sinemet (CR-4): a double-blind crossover study in patients with fluctuating Parkinson's disease. Mayo Clinic proceedings, 1988, Volume: 63, Issue:9 Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Consumer Behavior; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Evaluation; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation; Time Factors	1988
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations. Neurology, 1988, Volume: 38, Issue:7 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Humans; Levodopa; Middle Aged; Motor Activity; Parkinson Disease	1988
A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:4 Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Follow-Up Studies; Humans; Levodopa; Neurologic Examination; Parkinson Disease	1987
A double-blind evaluation of ciladopa in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:3 Topics: Aged; Carbidopa; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Piperazines; Random Allocation	1987
Clinical significance of the relationship between O-methyldopa levels and levodopa intake. Neurology, 1988, Volume: 38, Issue:4 Topics: Animals; Carbidopa; Corpus Striatum; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Parkinson Disease; Rats; Rats, Inbred Strains; Tyrosine	1988
Comparison of controlled-release Sinemet (CR4) and standard Sinemet (25 mg/100 mg) in advanced Parkinson's disease: a double-blind, crossover study. Clinical neuropharmacology, 1988, Volume: 11, Issue:2 Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1988
Treatment of chronic Parkinson's disease with controlled-release carbidopa/levodopa. Archives of neurology, 1988, Volume: 45, Issue:8 Topics: Aged; Carbidopa; Chronic Disease; Delayed-Action Preparations; Disability Evaluation; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1988
Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa. Advances in neurology, 1987, Volume: 45 Topics: Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation	1987
Parallel double-blind study of pergolide in Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Motor Skills; Parkinson Disease; Pergolide; Random Allocation	1987
Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Random Allocation	1987
Controlled release levodopa-carbidopa (CR-5) in the management of parkinsonian motor fluctuations. Archives of neurology, 1987, Volume: 44, Issue:10 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Time Factors	1987
Double-blind trial of pergolide for Parkinson's disease. Neurology, 1985, Volume: 35, Issue:3 Topics: Aged; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Ergolines; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide	1985
Motor function in the normal aging population: treatment with levodopa. Neurology, 1985, Volume: 35, Issue:4 Topics: Aged; Aging; Carbidopa; Dopamine; Drug Combinations; Humans; Levodopa; Middle Aged; Movement; Movement Disorders; Parkinson Disease	1985

Other Studies

324 other study(ies) available for carbidopa, levodopa drug combination and Parkinson Disease

Article	Year
Levodopa Carbidopa Intestinal Gel in Advanced Parkinson's Disease: DUOGLOBE Final 3-Year Results. Journal of Parkinson's disease, 2023, Volume: 13, Issue:5 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Gels; Humans; Levodopa; Parkinson Disease; Prospective Studies; Quality of Life	2023
Rescue levodopa-carbidopa intestinal gel (LCIG) therapy in Parkinson's disease patients with suboptimal response to deep brain stimulation. Annals of clinical and translational neurology, 2019, Volume: 6, Issue:10 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Combined Modality Therapy; Deep Brain Stimulation; Drug Combinations; Female; Gels; Humans; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Retrospective Studies	2019
[Chronic inflammatory demyelinating polyradiculoneuropathy associated with treatment using intraduodenal infusion of levodopa-carbidopa]. Revista de neurologia, 2019, 10-01, Volume: 69, Issue:7 Topics: Antiparkinson Agents; Carbidopa; Diagnosis, Differential; Dopamine; Drug Combinations; Duodenum; Female; Folic Acid; Humans; Infusions, Parenteral; Levodopa; Metabolic Networks and Pathways; Methionine; Middle Aged; Parkinson Disease; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	2019
Endoscopic management of duodenal levodopa-carbidopa therapy of advanced Parkinson's disease. Revista espanola de enfermedades digestivas, 2019, Volume: 111, Issue:11 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Duodenoscopy; Female; Gastrostomy; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies	2019
Investigating Stochastic Differential Equations Modelling for Levodopa Infusion in Patients with Parkinson's Disease. European journal of drug metabolism and pharmacokinetics, 2020, Volume: 45, Issue:1 Topics: Aged; Antiparkinson Agents; Biological Availability; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Models, Biological; Parkinson Disease; Precision Medicine; Stochastic Processes	2020
Long-term safety and efficacy of 24-hour levodopa-carbidopa intestinal gel in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:11 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome	2019
Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors. Parkinsonism & related disorders, 2020, Volume: 76 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Cause of Death; Drug Combinations; Female; Humans; Infusions, Parenteral; Levodopa; Longitudinal Studies; Male; Mental Status and Dementia Tests; Middle Aged; Parkinson Disease; Prognosis; Retrospective Studies	2020
Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: A large single-center study. Revue neurologique, 2020, Volume: 176, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Catheters, Indwelling; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Endoscopy, Gastrointestinal; Female; France; Gastrostomy; Gels; Humans; Infusion Pumps; Intestinal Absorption; Levodopa; Male; Mental Status and Dementia Tests; Middle Aged; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2020
Multicenter study of levodopa carbidopa intestinal gel in Parkinson’s disease: the Turkish experience Turkish journal of medical sciences, 2020, 02-13, Volume: 50, Issue:1 Topics: Activities of Daily Living; Aged; Carbidopa; Drug Combinations; Female; Gels; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reproducibility of Results	2020
Complex dyskinesias in Parkinson patients on levodopa/carbidopa intestinal gel. Parkinsonism & related disorders, 2019, Volume: 69 Topics: Aged; Antiparkinson Agents; Carbidopa; Case-Control Studies; Cross-Sectional Studies; Drug Combinations; Dyskinesia, Drug-Induced; Female; Gels; Humans; Intestines; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Retrospective Studies	2019
Clinical Trial Highlights - Infusion Therapies. Journal of Parkinson's disease, 2020, Volume: 10, Issue:1 Topics: Apomorphine; Carbidopa; Clinical Trials as Topic; Dopamine Agonists; Drug Combinations; Gels; Humans; Infusion Pumps, Implantable; Infusions, Subcutaneous; Jejunum; Levodopa; Parkinson Disease	2020
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment. Journal of neurosurgical sciences, 2020, Volume: 64, Issue:3 Topics: Carbidopa; Cognition; Cognitive Dysfunction; Dietary Supplements; Drug Combinations; Female; Free Radicals; Humans; Levodopa; Male; Middle Aged; Oxidative Stress; Parkinson Disease; Registries	2020
Compliance with levodopa-carbidopa intestinal gel in a selected population in central south Italy: Beyond sex, a possible gender effect. Parkinsonism & related disorders, 2020, Volume: 73 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Infusions, Parenteral; Italy; Levodopa; Male; Medication Adherence; Middle Aged; Parkinson Disease; Patient Dropouts; Sex Factors	2020
Levodopa infusion in Parkinson's disease: Individual quality of life. Acta neurologica Scandinavica, 2020, Volume: 142, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Caregivers; Cost of Illness; Drug Combinations; Female; Humans; Infusions, Parenteral; Jejunum; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Prospective Studies; Psychomotor Performance; Quality of Life; Treatment Outcome	2020
Biphasic Levodopa-Induced Freezing of Gait in Parkinson's Disease. Journal of Parkinson's disease, 2020, Volume: 10, Issue:3 Topics: Aged; Carbidopa; Dopamine Agonists; Drug Combinations; Gait Disorders, Neurologic; Humans; Levodopa; Male; Parkinson Disease	2020
Carbidopa and Levodopa Extended Release Capsules in Patients with and without Troublesome and Non-Troublesome Dyskinesia. Journal of Parkinson's disease, 2020, Volume: 10, Issue:3 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Capsules; Carbidopa; Delayed-Action Preparations; Drug Administration Schedule; Drug Combinations; Dyskinesias; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2020
Opicapone and Levodopa-Carbidopa Intestinal Gel Infusion: The Way Forward Towards Cost Savings for Healthcare Systems? Journal of Parkinson's disease, 2020, Volume: 10, Issue:4 Topics: Aged; Carbidopa; Catechol O-Methyltransferase Inhibitors; Cost Savings; Delivery of Health Care; Dopamine Agonists; Drug Combinations; Female; Gels; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Levodopa; Male; Middle Aged; Oxadiazoles; Parkinson Disease; Retrospective Studies	2020
Quality Improvement in Parkinson's Disease: A Successful Program to Enhance Timely Administration of Levodopa in the Hospital. Journal of Parkinson's disease, 2020, Volume: 10, Issue:4 Topics: Aged; Carbidopa; Dopamine Agonists; Drug Combinations; Female; Hospital Departments; Hospitalization; Hospitals, Urban; Humans; Length of Stay; Levodopa; Male; Middle Aged; Parkinson Disease; Process Assessment, Health Care; Quality Improvement; Time Factors	2020
Real-Life Use of Levodopa/Carbidopa Intestinal Gel in Parkinson's Disease According to Analysis of Pump Data. Journal of Parkinson's disease, 2020, Volume: 10, Issue:4 Topics: Aged; Carbidopa; Dopamine Agonists; Drug Combinations; Female; Gels; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Levodopa; Male; Medication Adherence; Middle Aged; Parkinson Disease	2020
Predictors of Time to Discontinuation of Levodopa-Carbidopa Intestinal Gel Infusion: A Retrospective Cohort Study. Journal of Parkinson's disease, 2020, Volume: 10, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies	2020
Comprehensive assessment of levodopa-carbidopa intestinal gel for Turkish advanced Parkinson’s disease patients Turkish journal of medical sciences, 2021, 02-26, Volume: 51, Issue:1 Topics: Abdomen, Acute; Aged; Carbidopa; Catheterization; Deglutition Disorders; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Dysarthria; Dyskinesias; Endoscopy; Female; Gait; Gels; Humans; Intestines; Levodopa; Male; Mental Status and Dementia Tests; Middle Aged; Parkinson Disease; Quality of Life; Severity of Illness Index; Treatment Outcome; Turkey	2021
Intrajejunal vs oral levodopa-carbidopa therapy in Parkinson disease: A retrospective cohort study. Medicine, 2020, Nov-13, Volume: 99, Issue:46 Topics: Administration, Oral; Aged; Aged, 80 and over; Carbidopa; Cohort Studies; Drug Combinations; Female; Humans; Injections; Jejunum; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Romania	2020
Parkinson Disease. American family physician, 2020, 12-01, Volume: 102, Issue:11 Topics: Antiparkinson Agents; Carbidopa; Combined Modality Therapy; Deep Brain Stimulation; Disease Progression; Drug Combinations; Family Practice; Humans; Levodopa; Parkinson Disease; Physical Therapy Modalities	2020
Real-world assessment of the impact of "OFF" episodes on health-related quality of life among patients with Parkinson's disease in the United States. BMC neurology, 2021, Jan-30, Volume: 21, Issue:1 Topics: Aged; Carbidopa; Cross-Sectional Studies; Drug Combinations; Female; Health Status; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Regression Analysis; Surveys and Questionnaires; Symptom Flare Up; United States	2021
Melanocytic Hyperactivation Simulating an Acral Lentiginous Melanoma in a Patient With Parkinson Disease Treated by Levodopa. The American Journal of dermatopathology, 2021, Mar-01, Volume: 43, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Diagnosis, Differential; Drug Combinations; Female; Humans; Hyperpigmentation; Levodopa; Melanins; Melanocytes; Melanoma; Parkinson Disease; Predictive Value of Tests; Skin; Skin Neoplasms; Skin Pigmentation; Treatment Outcome	2021
Buried Bumper Syndrome: A common complication of levodopa intestinal infusion for Parkinson disease. Parkinsonism & related disorders, 2021, Volume: 85 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Drug Combinations; Endoscopy, Gastrointestinal; Enteral Nutrition; Equipment Failure; Female; Gastrostomy; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Postoperative Complications; Prospective Studies; Retrospective Studies	2021
Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease. Annals of neurology, 2021, Volume: 90, Issue:1 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Levodopa; Parkinson Disease	2021
Levodopa/dopa decarboxylase inhibitor associated microscopic colitis: An under-recognized drug reaction. Parkinsonism & related disorders, 2021, Volume: 86 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benserazide; Carbidopa; Cohort Studies; Colitis, Microscopic; Drug Combinations; Enzyme Inhibitors; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies	2021
Pharmacological evaluation of vanillic acid in rotenone-induced Parkinson's disease rat model. European journal of pharmacology, 2021, Jul-15, Volume: 903 Topics: Animals; Antioxidants; Antiparkinson Agents; Behavior, Animal; Body Weight; Carbidopa; Catalase; Catalepsy; Disease Models, Animal; Dopamine; Drug Combinations; Female; Glutathione; Levodopa; Locomotion; Male; Mesencephalon; Muscular Diseases; Oxidative Stress; Parkinson Disease; Postural Balance; Rats, Sprague-Dawley; Rotenone; Superoxides; Thiobarbituric Acid Reactive Substances; Vanillic Acid	2021
The Social Value of Improvement in Activities of Daily Living among the Advanced Parkinson's Disease Population. Forum for health economics & policy, 2020, 11-25, Volume: 23, Issue:2 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Levodopa; Male; Parkinson Disease; Social Values	2020
The impact of tube replacement timing during LCIG therapy on PEG-J associated adverse events: a retrospective multicenter observational study. BMC neurology, 2021, Jun-25, Volume: 21, Issue:1 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Gastric Bypass; Gels; Humans; Levodopa; Parkinson Disease; Retrospective Studies	2021
Per-oral image guided gastrojejunostomy insertion for levodopa-carbidopa intestinal gel in Parkinson's disease is safe and may be advantageous. Parkinsonism & related disorders, 2021, Volume: 89 Topics: Aged; Antiparkinson Agents; Carbidopa; Digestive System Surgical Procedures; Drug Combinations; Female; Gastrostomy; Gels; Humans; Jejunum; Levodopa; Male; Middle Aged; Outcome and Process Assessment, Health Care; Parkinson Disease; Surgery, Computer-Assisted	2021
SCL20A2 mutation mimicking fluctuating Parkinson's disease. Parkinsonism & related disorders, 2017, Volume: 39 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Mutation; Parkinson Disease; Sodium-Phosphate Cotransporter Proteins, Type III	2017
Use of advanced therapies for Parkinson's disease in Norway. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2017, Volume: 137, Issue:9 Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Deep Brain Stimulation; Drug Combinations; Drug Utilization; Gels; Healthcare Disparities; Humans; Infusions, Parenteral; Levodopa; Norway; Parkinson Disease; Patient Education as Topic	2017
Liquid levodopa-carbidopa in advanced Parkinson's disease with motor complications. Journal of the neurological sciences, 2017, Jun-15, Volume: 377 Topics: Aged; Antiparkinson Agents; Ascorbic Acid; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Kaplan-Meier Estimate; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Treatment Outcome	2017
Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathy. Brain and behavior, 2017, Volume: 7, Issue:5 Topics: Administration, Oral; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Levodopa; Male; Parkinson Disease; Peripheral Nervous System Diseases; Vitamin B Complex	2017
Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation. Acta neurologica Scandinavica, 2017, Volume: 136, Issue:6 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Peripheral Nervous System Diseases; Pilot Projects; Prospective Studies; Vitamin B Complex; Vitamin D Deficiency	2017
Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017, Volume: 38, Issue:10 Topics: Aged; Antiparkinson Agents; Carbidopa; Central Nervous System; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Neural Conduction; Parkinson Disease; Peripheral Nervous System; Polyneuropathies; Prospective Studies	2017
Sulfasalazine-Induced Crystalluria Causing Severe Acute Kidney Injury. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017, Volume: 70, Issue:6 Topics: Acute Kidney Injury; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Carbidopa; Cholinesterase Inhibitors; Crohn Disease; Donepezil; Drug Combinations; Fluid Therapy; Humans; Indans; Kidney Calculi; Levodopa; Male; Parkinson Disease; Piperidines; Severity of Illness Index; Sulfasalazine; Ultrasonography	2017
Enteral feeding in Parkinson's patients receiving levodopa/carbidopa intestinal gel. Parkinsonism & related disorders, 2017, Volume: 42 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Enteral Nutrition; Gels; Humans; Levodopa; Male; Parkinson Disease	2017
Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease. Brain and behavior, 2017, Volume: 7, Issue:7 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Treatment Outcome; Weight Loss	2017
Cascade stomach associated with delayed-on or no-on phenomenon in a patient with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:10 Topics: Aged; Antiparkinson Agents; Barium; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Parkinson Disease; Radiography; Stomach Diseases	2017
Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusion. Brain and behavior, 2017, Volume: 7, Issue:8 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Administration Routes; Drug Combinations; Drug Monitoring; Female; Gels; Humans; Intestinal Absorption; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Quality of Life; Spain; Time; Treatment Outcome	2017
Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case report. Acta bio-medica : Atenei Parmensis, 2017, 08-23, Volume: 88, Issue:2 Topics: Aged; Carbidopa; Drug Combinations; Gels; Humans; Levodopa; Male; Parkinson Disease; Receptors, Dopamine; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch	2017
The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease. Journal of medical economics, 2017, Volume: 20, Issue:11 Topics: Antiparkinson Agents; Carbidopa; Cost-Benefit Analysis; Drug Combinations; Female; Gels; Health Expenditures; Health Resources; Humans; Ireland; Levodopa; Male; Markov Chains; Parkinson Disease; Quality-Adjusted Life Years	2017
Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease. Journal of Parkinson's disease, 2017, Volume: 7, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease; Sweden; Telemedicine; Time Factors; Treatment Outcome; Video Recording	2017
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry. Parkinsonism & related disorders, 2017, Volume: 45 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Intubation, Gastrointestinal; Levodopa; Male; Middle Aged; Parkinson Disease; Registries	2017
Levodopa-carbidopa intestinal gel therapy after deep brain stimulation. Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:2 Topics: Aged; Antiparkinson Agents; Carbidopa; Deep Brain Stimulation; Drug Combinations; Female; Gels; Humans; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Treatment Outcome	2018
The Design and Evaluation of an l-Dopa-Lazabemide Prodrug for the Treatment of Parkinson's Disease. Molecules (Basel, Switzerland), 2017, Nov-27, Volume: 22, Issue:12 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biological Availability; Carbidopa; Corpus Striatum; Dopamine; Drug Combinations; HeLa Cells; Humans; Levodopa; Male; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Permeability; Picolinic Acids; Prodrugs; Solubility; Structure-Activity Relationship	2017
l-Dopa/carbidopa intestinal gel and subthalamic nucleus stimulation: Effects on cognition and behavior. Brain and behavior, 2017, Volume: 7, Issue:11 Topics: Aged; Antiparkinson Agents; Carbidopa; Cognition; Deep Brain Stimulation; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Subthalamic Nucleus; Treatment Outcome	2017
Patient Preferences for Device-Aided Treatments Indicated for Advanced Parkinson Disease. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2017, Volume: 20, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Choice Behavior; Deep Brain Stimulation; Drug Combinations; Drug Delivery Systems; Duodenum; Equipment Design; Female; Humans; Infusion Pumps; Internet; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Preference; Surveys and Questionnaires; United States	2017
Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease. Journal of the neurological sciences, 2018, 02-15, Volume: 385 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gait Disorders, Neurologic; Gels; Humans; Intestines; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome	2018
Prelemniscal Lesion for Selective Improvement of Parkinson Disease Tremor. Stereotactic and functional neurosurgery, 2018, Volume: 96, Issue:1 Topics: Aged; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Parkinson Disease; Treatment Outcome; Tremor; Ventral Thalamic Nuclei	2018
A wrinkle in ON-time - A GI structural abnormality confounding levodopa therapy with Duodopa rescue; a case study. Parkinsonism & related disorders, 2018, Volume: 50 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Hernia, Hiatal; Humans; Levodopa; Male; Parkinson Disease	2018
Caregiver burden and its related factors in advanced Parkinson's disease: data from the PREDICT study. Journal of neurology, 2018, Volume: 265, Issue:5 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Apomorphine; Carbidopa; Caregivers; Cost of Illness; Cross-Sectional Studies; Drug Combinations; Family; Female; Humans; Italy; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Satisfaction; Quality of Life; Socioeconomic Factors; Surveys and Questionnaires; Treatment Outcome	2018
Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease. Journal of neurology, 2018, Volume: 265, Issue:6 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Caregivers; Comorbidity; Cost of Illness; Disruptive, Impulse Control, and Conduct Disorders; Drug Combinations; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastrostomy; Gels; Humans; Levodopa; Male; Parkinson Disease; Prospective Studies; Psychotropic Drugs; Quality of Life; Severity of Illness Index; Sleep; Treatment Outcome	2018
Workforce participation and activities in Parkinson's disease patients receiving device-aided therapy. Acta neurologica Scandinavica, 2018, Volume: 138, Issue:1 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Apomorphine; Carbidopa; Deep Brain Stimulation; Denmark; Drug Combinations; Female; Gels; Humans; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease; Pilot Projects; Retrospective Studies; Sweden	2018
Jejunal pulling syndrome: A peculiar LCIG complication. Parkinsonism & related disorders, 2018, Volume: 52 Topics: Aged; Antiparkinson Agents; Bezoars; Carbidopa; Drug Combinations; Gastric Bypass; Gels; Humans; Infusions, Parenteral; Intestinal Volvulus; Jejunum; Levodopa; Male; Parkinson Disease	2018
Levodopa-carbidopa intestinal gel: is the naso-jejunal phase a redundant convention? Internal medicine journal, 2018, Volume: 48, Issue:4 Topics: Administration, Intranasal; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gastrostomy; Gels; Humans; Infusion Pumps, Implantable; Jejunostomy; Jejunum; Length of Stay; Levodopa; Male; Middle Aged; Parkinson Disease	2018
Age/disease duration influence on activities of daily living and quality of life after levodopa-carbidopa intestinal gel in Parkinson's disease. Neurodegenerative disease management, 2018, Volume: 8, Issue:3 Topics: Activities of Daily Living; Age Factors; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Europe; Female; Gels; Humans; International Cooperation; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Surveys and Questionnaires; Treatment Outcome	2018
Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry. CNS neuroscience & therapeutics, 2018, Volume: 24, Issue:5 Topics: Accelerometry; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Parkinson Disease; Precision Medicine; Quality of Life; Single-Blind Method; Tablets; Treatment Outcome	2018
Acute cholecystitis induced by surgery for levodopa-carbidopa intestinal gel therapy: Possible relationship to pre-existing gallstones. Parkinsonism & related disorders, 2018, Volume: 54 Topics: Aged; Antiparkinson Agents; Carbidopa; Cholecystitis, Acute; Drug Combinations; Gallstones; Humans; Infusions, Parenteral; Jejunostomy; Levodopa; Male; Parkinson Disease	2018
Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson's disease patients. European journal of clinical pharmacology, 2018, Volume: 74, Issue:10 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Case-Control Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Parkinson Disease; Tablets; Young Adult	2018
[Outpatient establishment and initial management of treatment with intraduodenal levodopa-carbidopa infusion in advanced Parkinson's disease]. Revista de neurologia, 2018, Jul-01, Volume: 67, Issue:1 Topics: Aged; Algorithms; Ambulatory Care; Antiparkinson Agents; Carbidopa; Clinical Protocols; Disease Management; Drug Combinations; Duodenum; Female; Gastrostomy; Humans; Infusions, Parenteral; Intestinal Absorption; Intubation, Gastrointestinal; Levodopa; Male; Parkinson Disease	2018
Assessment of Duodopa Journal of neurology, 2018, Volume: 265, Issue:9 Topics: Aged; Antiparkinson Agents; Carbidopa; Caregivers; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Quality of Life; Treatment Outcome	2018
Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach. Current medical research and opinion, 2018, Volume: 34, Issue:12 Topics: Activities of Daily Living; Adolescent; Adult; Aged; Antiparkinson Agents; Carbidopa; Consensus; Drug Combinations; Europe; Female; Gels; Humans; Levodopa; Male; Parkinson Disease; Specialization; Young Adult	2018
Levodopa-Carbidopa-Related Rash in Parkinson's Disease: A Case Series. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2018, Volume: 45, Issue:5 Topics: Adult; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Drug Combinations; Exanthema; Female; Humans; Levodopa; Middle Aged; Parkinson Disease	2018
[Levodopa-carbidopa intestinal gel treatment introduced by surgical gastrostomy in a patient of Parkinson's disease after Billroth II gastrojejunostomy]. Rinsho shinkeigaku = Clinical neurology, 2018, Sep-28, Volume: 58, Issue:9 Topics: Aged; Antiparkinson Agents; Carbidopa; Dosage Forms; Drug Combinations; Drug Compounding; Duodenal Ulcer; Gastric Bypass; Gastrostomy; Gels; Humans; Levodopa; Male; Parkinson Disease; Treatment Outcome	2018
The effect of continuous levodopa treatment during the afternoon hours. Acta neurologica Scandinavica, 2019, Volume: 139, Issue:1 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Infusion Pumps, Implantable; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Time Factors	2019
Possible modulation of concurrent Parkinson's disease in the management of metastatic GIST: a review of two cases. The journal of the Royal College of Physicians of Edinburgh, 2018, Volume: 48, Issue:3 Topics: Aged; Antineoplastic Agents; Antiparkinson Agents; Carbidopa; Drug Combinations; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Levodopa; Liver Neoplasms; Male; Parkinson Disease; Severity of Illness Index; Stomach Neoplasms	2018
Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease. European journal of neurology, 2019, Volume: 26, Issue:3 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Weight Loss	2019
Burden of non-motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa-carbidopa intestinal gel. European journal of neurology, 2019, Volume: 26, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Cost of Illness; Drug Combinations; Female; Gels; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome	2019
Proposition of zinc supplementation during levodopa-carbidopa intestinal gel treatment. Brain and behavior, 2018, Volume: 8, Issue:12 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Administration Routes; Drug Combinations; Female; Gels; Humans; Levodopa; Male; Parkinson Disease; Prospective Studies; Zinc	2018
Conversion of L-dopa to Extended Release L-dopa (Rytary®) in Patients with Fluctuating Parkinson's Disease: Predictors of Dose. Journal of Parkinson's disease, 2019, Volume: 9, Issue:1 Topics: Aged; Carbidopa; Delayed-Action Preparations; Drug Combinations; Drug Substitution; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Patient Preference; Retrospective Studies	2019
Evaluation of D1/D5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration. Neuro-degenerative diseases, 2018, Volume: 18, Issue:5-6 Topics: Administration, Oral; Aged; Antiparkinson Agents; Carbidopa; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome	2018
Cost-utility analysis of levodopa carbidopa intestinal gel (Duodopa) in the treatment of advanced Parkinson's disease in patients in Scotland and Wales. Journal of medical economics, 2019, Volume: 22, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Cost-Benefit Analysis; Drug Combinations; Gels; Health Expenditures; Health Services; Health Status; Humans; Infusion Pumps, Implantable; Levodopa; Markov Chains; Models, Econometric; Parkinson Disease; Quality-Adjusted Life Years; Scotland; Severity of Illness Index; Wales	2019
Levodopa-carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry. Neurodegenerative disease management, 2019, Volume: 9, Issue:1 Topics: Aged; Carbidopa; Dopamine Agents; Drug Combinations; Dyskinesias; Female; Gels; Humans; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Quality of Life; Registries	2019
Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation. Journal of Parkinson's disease, 2019, Volume: 9, Issue:1 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Time Factors	2019
Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experience. Journal of neurology, 2019, Volume: 266, Issue:3 Topics: Actigraphy; Administration, Oral; Aged; Aged, 80 and over; Algorithms; Antiparkinson Agents; Carbidopa; Drug Combinations; Feasibility Studies; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Wearable Electronic Devices	2019
[Analysis of PEG-J associated complications in 14 adult patients treated with levodopa-carbidopa intestinal gel]. Rinsho shinkeigaku = Clinical neurology, 2019, Mar-28, Volume: 59, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Duodenal Diseases; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastrostomy; Gels; Humans; Intestinal Perforation; Jejunostomy; Levodopa; Male; Middle Aged; Parkinson Disease; Peritonitis; Retrospective Studies; Skin Diseases; Surgical Stomas	2019
[Complications and troubleshooting at the initial introduction of Levodopa-carbidopa continuous infusion gel therapy: A single-center study]. Rinsho shinkeigaku = Clinical neurology, 2019, Apr-25, Volume: 59, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gastric Bypass; Gastrostomy; Gels; Glycosides; Humans; Infusion Pumps; Intubation; Levodopa; Male; Middle Aged; Parkinson Disease; Pregnanes; Retrospective Studies; Skin Diseases, Infectious	2019
Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson's disease. Acta neurologica Scandinavica, 2019, Volume: 140, Issue:2 Topics: Administration, Mucosal; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gait; Gels; Humans; Intestinal Mucosa; Levodopa; Male; Middle Aged; Parkinson Disease; Postural Balance	2019
Dyskinesia-Hyperpyrexia Syndrome in Parkinson's disease with Deep Brain Stimulation and high-dose levodopa/carbidopa and entacapone. Parkinsonism & related disorders, 2019, Volume: 64 Topics: Antiparkinson Agents; Carbidopa; Catechols; Combined Modality Therapy; Deep Brain Stimulation; Drug Combinations; Drug Therapy, Combination; Fever; Humans; Hyperkinesis; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease	2019
Dopamine dysregulation syndrome induced by proxy. BMJ case reports, 2019, May-16, Volume: 12, Issue:5 Topics: Aged; Carbidopa; Disruptive, Impulse Control, and Conduct Disorders; Drug Combinations; Female; Humans; Levodopa; Parkinson Disease; Substance-Related Disorders; Syndrome	2019
Continuous subcutaneous apomorphine infusion in Parkinson's disease: causes of discontinuation and subsequent treatment strategies. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2019, Volume: 40, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Apomorphine; Carbidopa; Cognitive Dysfunction; Deep Brain Stimulation; Dopamine Agonists; Drug Combinations; Drug Substitution; Electronic Health Records; Female; Humans; Infusions, Subcutaneous; Levodopa; Male; Medication Adherence; Middle Aged; Parkinson Disease; Retrospective Studies	2019
Technique and outcome of percutaneous endoscopic transgastric jejunostomy for continuous infusion of levodopa-carbidopa intestinal gel for treatment of Parkinson's disease. Scandinavian journal of gastroenterology, 2019, Volume: 54, Issue:6 Topics: Aged; Aged, 80 and over; Carbidopa; Drug Combinations; Endoscopy, Gastrointestinal; Female; Gels; Humans; Jejunostomy; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Retrospective Studies; Treatment Outcome	2019
Motor and non-motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study. Journal of neurology, 2019, Volume: 266, Issue:9 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Cohort Studies; Drug Combinations; Female; Follow-Up Studies; Gastrostomy; Gels; Humans; Infusion Pumps; Italy; Jejunum; Levodopa; Male; Mental Status and Dementia Tests; Middle Aged; Parkinson Disease; Prospective Studies; Retrospective Studies; Treatment Outcome	2019
Levodopa/carbidopa intestinal gel infusion can improve camptocormia in Parkinson's disease. Parkinsonism & related disorders, 2019, Volume: 65 Topics: Aged; Carbidopa; Dopamine Agonists; Drug Combinations; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Muscular Atrophy, Spinal; Parkinson Disease; Spinal Curvatures; Treatment Outcome	2019
Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation. Journal of neural transmission (Vienna, Austria : 1996), 2019, Volume: 126, Issue:7 Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Deep Brain Stimulation; Drug Combinations; Gels; Germany; Humans; Infusions, Parenteral; Infusions, Subcutaneous; Levodopa; Neurology; Parkinson Disease; Practice Patterns, Physicians'	2019
Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety. Journal of Parkinson's disease, 2019, Volume: 9, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gastrostomy; Gels; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Jejunum; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Registries; Retrospective Studies	2019
Extended-release carbidopa-levodopa in Parkinson's disease. The Lancet. Neurology, 2013, Volume: 12, Issue:4 Topics: Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Motor Skills Disorders; Parkinson Disease	2013
Mydriasis in a Parkinson disease patient on low-dose carbidopa/levodopa. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Middle Aged; Mydriasis; Parkinson Disease	2013
Heterotopic ossification following distal radius fractures in a patient with Parkinson disease treated with levodopa-carbidopa. The Journal of hand surgery, 2013, Volume: 38, Issue:6 Topics: Antiparkinson Agents; Carbidopa; Causality; Drug Combinations; Fracture Fixation, Internal; Humans; Levodopa; Male; Middle Aged; Ossification, Heterotopic; Parkinson Disease; Radiography; Radius Fractures	2013
Guillain-Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment. Parkinsonism & related disorders, 2014, Volume: 20, Issue:1 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Guillain-Barre Syndrome; Humans; Levodopa; Parkinson Disease; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	2014
Drugs for Parkinson's disease. Treatment guidelines from the Medical Letter, 2013, Volume: 11, Issue:135 Topics: Antiparkinson Agents; Carbidopa; Catechol O-Methyltransferase Inhibitors; Cholinergic Antagonists; Deep Brain Stimulation; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease	2013
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience. European journal of neurology, 2014, Volume: 21, Issue:2 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome	2014
Intestinal levodopa infusion: the Belgian experience. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2014, Volume: 35, Issue:6 Topics: Aged; Antiparkinson Agents; Belgium; Carbidopa; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Satisfaction; Treatment Outcome	2014
Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients. Journal of neural transmission (Vienna, Austria : 1996), 2014, Volume: 121, Issue:6 Topics: Aged; Amantadine; Antiparkinson Agents; Apomorphine; Carbidopa; Caregivers; Drug Administration Routes; Drug Combinations; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Patient Selection; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome	2014
Do adipose tissue-derived mesenchymal stem cells ameliorate Parkinson's disease in rat model? Human & experimental toxicology, 2014, Volume: 33, Issue:12 Topics: Adipose Tissue; Amino Acids; Animals; Antigens, CD; Brain; Brain-Derived Neurotrophic Factor; Carbidopa; Cell Differentiation; Cells, Cultured; Chemokine CCL2; Disease Models, Animal; Drug Combinations; Female; Gene Expression; Genes, sry; Levodopa; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Ovariectomy; Parkinson Disease; Rats, Sprague-Dawley; Rotenone; Transforming Growth Factor beta; Tyrosine 3-Monooxygenase	2014
Subacute peripheral neuropathy under duodopa therapy without cobalamin deficiency and despite supplementation. Journal of neural transmission (Vienna, Austria : 1996), 2014, Volume: 121, Issue:10 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Infusions, Parenteral; Jejunum; Levodopa; Male; Parkinson Disease; Polyneuropathies; Vitamin B 12	2014
Gastric bezoar complication of Duodopa(®) therapy in Parkinson's disease, treated with Coca-Cola(®). Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:8 Topics: Aged; Antiparkinson Agents; Bezoars; Carbidopa; Carbonated Beverages; Drug Combinations; Humans; Levodopa; Male; Parkinson Disease; Stomach	2014
Successful treatment of dopamine dysregulation syndrome with valproic acid. The Journal of neuropsychiatry and clinical neurosciences, 2014,Summer, Volume: 26, Issue:3 Topics: Antimanic Agents; Carbidopa; Compulsive Behavior; Dopamine Agonists; Drug Combinations; Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Valproic Acid	2014
Teaching NeuroImages: Pisa syndrome in Parkinson disease. Neurology, 2014, Nov-04, Volume: 83, Issue:19 Topics: Aged; Carbidopa; Drug Combinations; Dystonia; Humans; Indoles; Levodopa; Male; Parkinson Disease; Posture; Scoliosis	2014
24 h Levodopa-carbidopa intestinal gel may reduce falls and "unresponsive" freezing of gait in Parkinson's disease. Parkinsonism & related disorders, 2015, Volume: 21, Issue:3 Topics: Accidental Falls; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gait Disorders, Neurologic; Gels; Humans; Jejunum; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Time Factors	2015
Dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion: Management inclinical practice. Parkinsonism & related disorders, 2015, Volume: 21, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Gels; Humans; Jejunum; Levodopa; Parkinson Disease	2015
Initiating intrajejunal infusion of levodopa/carbidopa intestinal gel: an outpatient model. Movement disorders : official journal of the Movement Disorder Society, 2015, Volume: 30, Issue:4 Topics: Carbidopa; Drug Combinations; Gels; Humans; Jejunum; Levodopa; Outpatients; Parkinson Disease	2015
New and emerging treatments for Parkinson disease. The Medical journal of Australia, 2015, Apr-06, Volume: 202, Issue:6 Topics: Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Deep Brain Stimulation; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome	2015
Knotting of Duodopa® duodenal infusion system. Revista espanola de enfermedades digestivas, 2015, Volume: 107, Issue:5 Topics: Aged; Antiparkinson Agents; Carbidopa; Catheterization; Catheters; Drug Combinations; Duodenum; Equipment Failure; Female; Humans; Infusion Pumps; Levodopa; Male; Middle Aged; Parkinson Disease	2015
Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion. Parkinsonism & related disorders, 2015, Volume: 21, Issue:8 Topics: Aged; Anhedonia; Apathy; Carbidopa; Dopamine Agonists; Drug Combinations; Female; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Substance Withdrawal Syndrome	2015
Depression, anxiety and non-motor symptoms on initiation of intrajejunal levodopa/carbidopa therapy. Acta neurologica Belgica, 2016, Volume: 116, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Anxiety; Carbidopa; Depression; Drug Combinations; Female; Humans; Jejunum; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Psychiatric Status Rating Scales; Time Factors	2016
Electroencephalographic lateralization, clinical correlates and pharmacological response in untreated Parkinson's disease. Parkinsonism & related disorders, 2015, Volume: 21, Issue:8 Topics: Aged; Alpha Rhythm; Antiparkinson Agents; Beta Rhythm; Carbidopa; Drug Combinations; Electroencephalography; Female; Frontal Lobe; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Occipital Lobe; Parkinson Disease; Severity of Illness Index	2015
Dopamine dysregulation syndrome and punding in levodopa-carbidopa intestinal gel (LCIG) infusion: A serious but preventable complication. Parkinsonism & related disorders, 2015, Volume: 21, Issue:9 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Drug Delivery Systems; Humans; Infusions, Parenteral; Levodopa; Male; Parkinson Disease	2015
Continuous duodenal levodopa infusion in a patient with Crohn's disease and small bowel surgery - Case report. Journal of the neurological sciences, 2015, Nov-15, Volume: 358, Issue:1-2 Topics: Antiparkinson Agents; Carbidopa; Crohn Disease; Drug Combinations; Duodenum; Humans; Intestine, Small; Levodopa; Male; Middle Aged; Parkinson Disease	2015
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel. Parkinsonism & related disorders, 2015, Volume: 21, Issue:11 Topics: Behavior, Addictive; Carbidopa; Dopamine Agonists; Drug Combinations; Humans; Levodopa; Parkinson Disease; Syndrome	2015
Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: a long-term prospective assessment. European journal of neurology, 2016, Volume: 23, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Peripheral Nervous System Diseases; Prospective Studies	2016
Levodopa-Carbidopa Intestinal Gel Infusion Therapy in Advanced Parkinson's Disease: Single Middle Eastern Center Experience. European neurology, 2015, Volume: 74, Issue:5-6 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Disability Evaluation; Drug Combinations; Duodenum; Female; Gels; Humans; Infusions, Parenteral; Intubation, Gastrointestinal; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prospective Studies; Quality of Life	2015
Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials. Movement disorders : official journal of the Movement Disorder Society, 2016, Volume: 31, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Clinical Trials, Phase III as Topic; Drug Combinations; Female; Gastric Bypass; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Multicenter Studies as Topic; Outcome Assessment, Health Care; Parkinson Disease; Prospective Studies	2016
The effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experience. Journal of neural transmission (Vienna, Austria : 1996), 2016, Volume: 123, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gastric Bypass; Gels; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Quality of Life; Retrospective Studies; Romania	2016
Compensatory striatal-cerebellar connectivity in mild-moderate Parkinson's disease. NeuroImage. Clinical, 2016, Volume: 10 Topics: Aged; Brain Mapping; Carbidopa; Caudate Nucleus; Cerebellum; Drug Combinations; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Motor Activity; Motor Cortex; Neural Pathways; Parkinson Disease; Putamen; Severity of Illness Index	2016
A case of severe leg oedema in a patient with Parkinson's disease treated with pramipexole. Postgraduate medical journal, 2016, Volume: 92, Issue:1090 Topics: Antiparkinson Agents; Benzothiazoles; Carbidopa; Drug Combinations; Drug Therapy, Combination; Edema; Humans; Leg; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Treatment Outcome	2016
24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2016, Volume: 31, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Muscle Rigidity; Outcome Assessment, Health Care; Parkinson Disease; Sleep Wake Disorders	2016
Physicians' experience with RYTARY (carbidopa and levodopa) extended-release capsules in patients who have Parkinson disease. Neurology, 2016, Apr-05, Volume: 86, Issue:14 Suppl 1 Topics: Antiparkinson Agents; Capsules; Carbidopa; Delayed-Action Preparations; Drug Combinations; Drug Substitution; Humans; Levodopa; Parkinson Disease; Physicians	2016
Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa. Neurodegenerative disease management, 2016, Volume: 6, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Caregivers; Clinical Trials as Topic; Databases, Bibliographic; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Intestines; Levodopa; Male; Parkinson Disease; Treatment Outcome	2016
Advanced therapies in Parkinson's disease: Long-term retrospective study. Parkinsonism & related disorders, 2016, Volume: 29 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Carbidopa; Cohort Studies; Deep Brain Stimulation; Drug Combinations; Female; Gels; Humans; Intestines; Levodopa; Male; Middle Aged; Motor Activity; Neuropsychological Tests; Parkinson Disease; Severity of Illness Index; Thalamus; Treatment Outcome	2016
Outpatient titration of carbidopa/levodopa enteral suspension (Duopa). The International journal of neuroscience, 2017, Volume: 127, Issue:5 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Outpatients; Parkinson Disease; Suspensions; Treatment Outcome	2017
Endoscopic alternative to buried bumper syndrome secondary to Duodopa Gastroenterologia y hepatologia, 2017, Volume: 40, Issue:5 Topics: Aged; Antiparkinson Agents; Carbidopa; Catheters, Indwelling; Device Removal; Drug Combinations; Emergencies; Equipment Design; Foreign-Body Migration; Gastroscopes; Gastroscopy; Gastrostomy; Humans; Infusion Pumps, Implantable; Levodopa; Male; Parkinson Disease; Tomography, X-Ray Computed	2017
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs. Parkinsonism & related disorders, 2016, Volume: 29 Topics: Aged; Antiparkinson Agents; Carbidopa; Cohort Studies; Drug Combinations; Female; Gels; Health Care Costs; Humans; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Statistics, Nonparametric; Visual Analog Scale	2016
Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study. European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:11 Topics: Activities of Daily Living; Antiparkinson Agents; Carbidopa; Drug Combinations; Endoscopy, Gastrointestinal; Gastrostomy; Humans; Levodopa; Parkinson Disease	2016
A potential case of remission of Parkinson's disease. Journal of complementary & integrative medicine, 2016, Sep-01, Volume: 13, Issue:3 Topics: Aged; Brain; Carbidopa; Dopamine; Drug Combinations; Humans; Levodopa; Male; Meditation; Parkinson Disease; Psychophysiology; Remission Induction	2016
Wearable Sensors for Advanced Therapy Referral in Parkinson's Disease. Journal of Parkinson's disease, 2016, 07-02, Volume: 6, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Deep Brain Stimulation; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Monitoring, Ambulatory; Parkinson Disease; Referral and Consultation; Retrospective Studies; Severity of Illness Index	2016
Motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2016, Volume: 37, Issue:11 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Infusions, Parenteral; Italy; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Quality of Life	2016
Plantar cutaneous function in Parkinson's disease patients ON and OFF L-dopa. Neuroscience letters, 2016, 08-26, Volume: 629 Topics: Aged; Carbidopa; Discrimination, Psychological; Drug Combinations; Electromyography; Female; Foot; Humans; Levodopa; Lower Extremity; Male; Middle Aged; Muscle, Skeletal; Parkinson Disease; Physical Stimulation; Reflex, Abnormal; Touch; Touch Perception; Vibration	2016
Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease. Neurodegenerative disease management, 2016, Volume: 6, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Cross-Sectional Studies; Drug Combinations; Female; Gels; Humans; Intestines; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Activity; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Spain	2016
Choosing an Advanced Therapy in Parkinson's Disease; is it an Evidence-Based Decision in Current Practice? Journal of Parkinson's disease, 2016, 07-25, Volume: 6, Issue:3 Topics: Apomorphine; Carbidopa; Caregivers; Clinical Decision-Making; Consumer Health Information; Deep Brain Stimulation; Dopamine Agonists; Drug Combinations; Evidence-Based Practice; Humans; Levodopa; Neurologists; Parkinson Disease; Patient Preference; Qualitative Research	2016
Levodopa/carbidopa intestinal gel therapy for advanced Parkinson Disease: AN early toxic effect for small nerve fibers? Muscle & nerve, 2016, Volume: 54, Issue:5 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome	2016
Authors' Reply to Lambarth: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review". CNS drugs, 2016, Volume: 30, Issue:10 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Gels; Humans; Intestines; Levodopa; Parkinson Disease; Review Literature as Topic	2016
Weight loss and decubitus duodenal ulcer in Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion. Journal of neural transmission (Vienna, Austria : 1996), 2016, Volume: 123, Issue:12 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Duodenal Ulcer; Duodenum; Dyskinesias; Endoscopes, Gastrointestinal; Humans; Levodopa; Male; Parkinson Disease; Tomography, X-Ray Computed; Weight Loss	2016
Jejunal catheter placement for levodopa-carbidopa infusion in a patient with Billroth I gastrectomy. Endoscopy, 2016, Volume: 48 Suppl 1 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Endoscopy, Gastrointestinal; Gastrectomy; Gastroenterostomy; Humans; Infusion Pumps; Intubation, Gastrointestinal; Jejunum; Levodopa; Male; Middle Aged; Parkinson Disease	2016
Necessity of long-term alertness in levodopa-carbidopa intestinal gel infusion for PD patients. Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:2 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Duodenal Ulcer; Female; Gastrostomy; Humans; Infusions, Parenteral; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease	2017
Jejunitis secondary to Duodopa® probe, a different complication. Revista espanola de enfermedades digestivas, 2016, Volume: 108, Issue:12 Topics: Aged; Antiparkinson Agents; Bezoars; Carbidopa; Drug Combinations; Endoscopy, Gastrointestinal; Female; Humans; Infusion Pumps, Implantable; Jejunal Diseases; Levodopa; Parkinson Disease	2016
Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease. Parkinsonism & related disorders, 2017, Volume: 37 Topics: Aged; Antiparkinson Agents; Carbidopa; Disability Evaluation; Drug Combinations; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Gels; Humans; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index	2017
Dyskinesias in levodopa-carbidopa intestinal gel infusion era: New challenges, new features. Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:4 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2017
Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson's disease: An open-label study. Parkinsonism & related disorders, 2017, Volume: 37 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Carbidopa; Disability Evaluation; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Treatment Outcome	2017
Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:5 Topics: Age Factors; Antiparkinson Agents; Bifidobacterium; Carbidopa; Case-Control Studies; Catechol O-Methyltransferase Inhibitors; Cholinergic Antagonists; Confounding Factors, Epidemiologic; Diet; Drug Combinations; Dysbiosis; Female; Fruit; Gastrointestinal Microbiome; Humans; Lactobacillaceae; Levodopa; Male; Parkinson Disease; Pasteurellaceae; Risk Factors; RNA, Ribosomal, 16S; Sex Factors; United States; Vegetables; Verrucomicrobia	2017
Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy. Journal of neural transmission (Vienna, Austria : 1996), 2017, Volume: 124, Issue:8 Topics: Algorithms; Antiparkinson Agents; Carbidopa; Combined Modality Therapy; Decision Support Systems, Clinical; Drug Combinations; Drug Therapy, Combination; Humans; Infusion Pumps; Levodopa; Parkinson Disease	2017
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up. Parkinsonism & related disorders, 2017, Volume: 38 Topics: Antiparkinson Agents; Carbidopa; Disease Progression; Drug Combinations; Female; Gels; Health Surveys; Humans; Intestines; Italy; Levodopa; Longitudinal Studies; Male; Parkinson Disease; Retrospective Studies; Substance Withdrawal Syndrome	2017
Prevalence and burden of dysautonomia in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:5 Topics: Activities of Daily Living; Antiparkinson Agents; Carbidopa; Cross-Sectional Studies; Deep Brain Stimulation; Drug Combinations; Female; Humans; Levodopa; Logistic Models; Male; Parkinson Disease; Prevalence; Primary Dysautonomias; Severity of Illness Index; Subthalamic Nucleus; Surveys and Questionnaires	2017
First clinical experience with levodopa/carbidopa microtablets in Parkinson's disease. Acta neurologica Scandinavica, 2017, Volume: 136, Issue:6 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tablets	2017
Sildenafil induced choreoathetosis in men with Parkinson's disease. International journal of clinical pharmacology and therapeutics, 2010, Volume: 48, Issue:1 Topics: Antiparkinson Agents; Athetosis; Carbidopa; Chorea; Drug Combinations; Drug Interactions; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones	2010
Levodopa-responsive parkinsonism after aneurysmal subarachnoid hemorrhage. Neurocritical care, 2010, Volume: 13, Issue:2 Topics: Adult; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Parkinson Disease; Subarachnoid Hemorrhage; Substantia Nigra	2010
Delayed-onset parkinsonian tremor following a mesencephalic lesion. Parkinsonism & related disorders, 2011, Volume: 17, Issue:1 Topics: Antiparkinson Agents; Carbidopa; Dopamine; Drug Combinations; Electromyography; Female; Humans; Levodopa; Magnetic Resonance Imaging; Mesencephalon; Middle Aged; Neurologic Examination; Parkinson Disease; Tegmentum Mesencephali; Tremor	2011
Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (Duodopa®) in Sweden. Applied health economics and health policy, 2010, Volume: 8, Issue:6 Topics: Antiparkinson Agents; Carbidopa; Drug Administration Routes; Drug Combinations; Drug Costs; Duodenum; Government Agencies; Humans; Levodopa; Models, Economic; Parkinson Disease; Reimbursement Mechanisms; Sweden; Treatment Outcome	2010
Parkinson disease: adjunctive entacapone therapy increases risk of dyskinesia. Nature reviews. Neurology, 2010, Volume: 6, Issue:11 Topics: Antiparkinson Agents; Carbidopa; Catechols; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Neurologic Examination; Nitriles; Parkinson Disease; Randomized Controlled Trials as Topic; Receptors, Dopamine	2010
Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Deep Brain Stimulation; Disability Evaluation; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Subthalamic Nucleus; Treatment Outcome	2011
Severe weight loss in a young Parkinson's disease patient: a multidisciplinary approach to diagnosis and treatment. The Israel Medical Association journal : IMAJ, 2011, Volume: 13, Issue:3 Topics: Antiparkinson Agents; Carbidopa; Caregivers; Disease Progression; Domestic Violence; Drug Combinations; Eating; Female; Humans; Hypertrichosis; Levodopa; Middle Aged; Nutritional Status; Parkinson Disease; Weight Loss	2011
Levodopa-induced breathing, cognitive and behavioral changes in Parkinson's disease. Journal of neurology, 2011, Volume: 258, Issue:12 Topics: Aged; Antiparkinson Agents; Carbidopa; Cognition Disorders; Drug Combinations; Humans; Levodopa; Male; Mental Disorders; Parkinson Disease; Respiration Disorders	2011
Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours. The International journal of neuroscience, 2011, Volume: 121, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Compulsive Behavior; Delusions; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales	2011
Executive control in Parkinson's disease: effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance. Neuroscience letters, 2011, Aug-15, Volume: 500, Issue:2 Topics: Aged; Benserazide; Benzothiazoles; Carbidopa; Cues; Deep Brain Stimulation; Dopamine Agents; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Psychomotor Performance; Reaction Time; Subthalamic Nucleus	2011
Duodopa infusion treatment: a point of view from the gastroenterologist. Journal of gastrointestinal and liver diseases : JGLD, 2011, Volume: 20, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gastroenterology; Gels; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Parkinson Disease	2011
Lees' syndrome: a case series. Arquivos de neuro-psiquiatria, 2011, Volume: 69, Issue:5 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dopamine; Dopamine Agents; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Syndrome	2011
Parkinson's disease patients cannot get their dopamine replacement: the 8-Sinemet limit. Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:3 Topics: Carbidopa; Dopamine; Dopamine Agonists; Drug Combinations; Humans; Levodopa; Parkinson Disease	2012
Nasogastric medication for perioperative Parkinson's rigidity during anaesthesia emergence. Anaesthesia and intensive care, 2011, Volume: 39, Issue:6 Topics: Amantadine; Anesthesia; Anesthesia Recovery Period; Anesthesia, General; Antiparkinson Agents; Carbidopa; Drug Combinations; Fracture Fixation, Internal; Fractures, Bone; Humans; Humerus; Intraoperative Awareness; Intubation, Gastrointestinal; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Perioperative Care	2011
Duodenal levodopa/carbidopa infusion therapy in patients with advanced Parkinson's disease leads to improvement in caregivers' stress and burden. European journal of neurology, 2012, Volume: 19, Issue:9 Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Carbidopa; Caregivers; Drug Combinations; Duodenostomy; Female; Humans; Infusion Pumps; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Quality of Life; Spouses; Stress, Psychological; Surveys and Questionnaires	2012
Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause? The journal of headache and pain, 2012, Volume: 13, Issue:3 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Burning Mouth Syndrome; Carbidopa; Dopamine; Dopamine Agonists; Drug Combinations; Female; Humans; Levodopa; Parkinson Disease; Pramipexole	2012
Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson's disease. European journal of neurology, 2012, Volume: 19, Issue:8 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Infusions, Parenteral; Intestines; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies	2012
Finasteride attenuates pathological gambling in patients with Parkinson disease. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:3 Topics: 5-alpha Reductase Inhibitors; Aged; Antiparkinson Agents; Benzothiazoles; Cabergoline; Carbidopa; Catechols; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Ergolines; Finasteride; Gambling; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Pramipexole; Treatment Outcome; Video Games	2012
Dopamine dysregulation syndrome including mania related to coadministration of droxidopa. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:3 Topics: Aggression; Antiparkinson Agents; Behavior, Addictive; Benzothiazoles; Bipolar Disorder; Carbidopa; Droxidopa; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Neurotoxicity Syndromes; Parkinson Disease; Pramipexole; Treatment Outcome	2012
Cysteine decrease following acute Levodopa intake in patients with Parkinson's disease. Neuroscience letters, 2012, Jul-11, Volume: 521, Issue:1 Topics: Administration, Oral; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Cysteine; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2012
Drugs for treating Parkinson disease. Nursing, 2012, Volume: 42, Issue:7 Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Catechols; Drug Combinations; Drugs, Generic; Humans; Indans; Levodopa; Nitriles; Parkinson Disease	2012
Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study. Journal of neurology, 2013, Volume: 260, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Cognition Disorders; Disability Evaluation; Drug Combinations; Duodenum; Female; Humans; Infusions, Parenteral; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Activity; Neuropsychological Tests; Parkinson Disease; Quality of Life; Statistics, Nonparametric	2013
Refractory epileptic seizures due to vitamin B6 deficiency in a patient with Parkinson's disease under duodopa® therapy. Journal of neural transmission (Vienna, Austria : 1996), 2013, Volume: 120, Issue:2 Topics: Aged; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Parkinson Disease; Seizures; Treatment Outcome; Vitamin B 6; Vitamin B 6 Deficiency	2013
Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease. Journal of neurology, 2013, Volume: 260, Issue:2 Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Anticonvulsants; Carbidopa; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Valproic Acid	2013
Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion. Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:13 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gastrointestinal Diseases; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease	2012
Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients. The AAPS journal, 2013, Volume: 15, Issue:2 Topics: Aged; Antiparkinson Agents; Biotransformation; Carbidopa; Chemistry, Pharmaceutical; Drug Combinations; Female; Gels; Germany; Humans; Infusion Pumps; Intestinal Absorption; Intubation, Gastrointestinal; Jejunum; Levodopa; Male; Middle Aged; Parkinson Disease; Sweden; Tyrosine	2013
Perioperative medication withholding in patients with Parkinson's disease: a retrospective electronic health records review. The American journal of nursing, 2013, Volume: 113, Issue:1 Topics: Aged; Antiparkinson Agents; Carbidopa; Comorbidity; Drug Combinations; Electronic Health Records; Female; Half-Life; Humans; Levodopa; Male; Parkinson Disease; Retrospective Studies; Surgical Procedures, Operative	2013
Acute dopaminergic challenge tests to assess postural/kinetic tremor of different origin: a case report. Journal of neurology, neurosurgery, and psychiatry, 2002, Volume: 73, Issue:2 Topics: Aged; Antiparkinson Agents; Apomorphine; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Electromyography; Essential Tremor; Female; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Posture; Receptors, Dopamine	2002
[The use of amantadine sulfate in combined therapy of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2002, Volume: 102, Issue:7 Topics: Aged; Amantadine; Carbidopa; Dopamine Agents; Drug Combinations; Drug Therapy, Combination; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	2002
Clozapine withdrawal symptoms in a Parkinson's disease patient. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6 Topics: Aged; Antipsychotic Agents; Carbidopa; Clozapine; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Substance Withdrawal Syndrome	2002
Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:2 Topics: Antiparkinson Agents; Carbidopa; Disability Evaluation; Drug Combinations; Female; Hip; Humans; Knee; Levodopa; Lower Extremity; Male; Middle Aged; Muscle Weakness; Muscle, Skeletal; Parkinson Disease; Posture; Random Allocation; Severity of Illness Index	2003
Parkinsonian speech disfluencies: effects of L-dopa-related fluctuations. Journal of fluency disorders, 2003,Spring, Volume: 28, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Basal Ganglia; Carbidopa; Dopamine; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Reading; Speech Production Measurement; Stuttering	2003
L-DOPA biotransformation: correlations of dosage, erythrocyte catechol O-methyltransferase and platelet SULT1A3 activities with metabolic pathways in Parkinsonian patients. Journal of neural transmission (Vienna, Austria : 1996), 2003, Volume: 110, Issue:8 Topics: Adenosine Diphosphate; Aged; Arylsulfotransferase; Biotransformation; Blood Platelets; Carbidopa; Catechol O-Methyltransferase; Dose-Response Relationship, Drug; Drug Combinations; Erythrocytes; Female; Humans; Levodopa; Male; Methylation; Middle Aged; Parkinson Disease; S-Adenosylmethionine; Sulfates	2003
Drug adherence in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:5 Topics: Aged; Antiparkinson Agents; Carbidopa; Chronic Disease; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Female; Humans; Levodopa; Male; Medication Systems; Parkinson Disease; Patient Compliance; Surveys and Questionnaires	2004
Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:6 Topics: Adult; Aged; Cabergoline; Carbidopa; Dopamine Agonists; Drug Combinations; Echocardiography, Transesophageal; Ergolines; Ergot Alkaloids; Female; Heart Valve Diseases; Humans; Levodopa; Male; Parkinson Disease; Pergolide	2004
An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate. Behavioural brain research, 2005, Jan-30, Volume: 156, Issue:2 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Carbidopa; Cell Count; Differential Threshold; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Immunohistochemistry; Levodopa; Male; Methylphenidate; Motor Activity; Movement; Nerve Degeneration; Neurons; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Long-Evans; Rotarod Performance Test; Substantia Nigra; Tyrosine 3-Monooxygenase	2005
[18F]FDOPA PET and clinical features in parkinsonism due to manganism. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:4 Topics: Adult; Antiparkinson Agents; Brain; Carbidopa; Drug Combinations; Female; Fluorodeoxyglucose F18; Gait; Humans; Levodopa; Magnetic Resonance Imaging; Manganese Poisoning; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals	2005
Parcopa: a rapidly dissolving formulation of carbidopa/levodopa. The Medical letter on drugs and therapeutics, 2005, Jan-31, Volume: 47, Issue:1201 Topics: Administration, Oral; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Fees, Pharmaceutical; Humans; Levodopa; Parkinson Disease	2005
Psychiatric sequelae of Parkinson disease: a case report. European psychiatry : the journal of the Association of European Psychiatrists, 2006, Volume: 21, Issue:3 Topics: Antiparkinson Agents; Cabergoline; Carbidopa; Compulsive Behavior; Drug Combinations; Ergolines; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sex Offenses	2006
Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease	2006
Augmentation of artistic productivity in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:2 Topics: Antiparkinson Agents; Art; Carbidopa; Creativity; Dopamine Agents; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Frontal Lobe; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Poetry as Topic	2006
[Dopamine receptors agonists (mirapex) in the treatment of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2006, Volume: 106, Issue:6 Topics: Anxiety; Benzothiazoles; Carbidopa; Delayed-Action Preparations; Depression; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Receptors, Dopamine D1; Thiazoles; Treatment Outcome	2006
Skin rash associated with Sinemet does not equal levodopa allergy. Neurology, 2007, Mar-27, Volume: 68, Issue:13 Topics: Aged; Antiparkinson Agents; Carbidopa; Coloring Agents; Drug Combinations; Drug Eruptions; Drug Hypersensitivity; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Skin; Withholding Treatment	2007
Complicated response fluctuations in Parkinson's disease: response to intravenous infusion of levodopa. Lancet (London, England), 1982, Aug-21, Volume: 2, Issue:8295 Topics: Administration, Oral; Carbidopa; Dopamine; Drug Combinations; Humans; Infusions, Parenteral; Kinetics; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Adrenergic; Time Factors	1982
Cholinergic and dopaminergic mechanisms in Parkinson's disease after long term levodopa administration. Lancet (London, England), 1982, Sep-25, Volume: 2, Issue:8300 Topics: Carbidopa; Drug Combinations; Humans; Levodopa; Parkinson Disease; Receptors, Cholinergic; Receptors, Dopamine; Time Factors	1982
[Circadian rhythm of catecholamine excretion, effect of L-DOPA and Nacom in various diseases of the nervous system]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1983, Volume: 83, Issue:12 Topics: Adult; Aged; Carbidopa; Catecholamines; Drug Combinations; Dystonia Musculorum Deformans; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Muscular Dystrophies; Nervous System Diseases; Neurotic Disorders; Parkinson Disease	1983
Urinary homovanillic acid and c-AMP in drug-free Parkinson patients: effect of L-dopa treatment. European neurology, 1981, Volume: 20, Issue:2 Topics: Aged; Carbidopa; Cyclic AMP; Drug Combinations; Female; Homovanillic Acid; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phenylacetates	1981
Severity of Parkinson's disease and the dosage of bromocriptine. Neurology, 1984, Volume: 34, Issue:6 Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies	1984
One-year trial of pergolide as an adjunct to Sinemet in treatment of Parkinson's disease. Advances in neurology, 1984, Volume: 40 Topics: Athetosis; Carbidopa; Chorea; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Ergolines; Humans; Hypotension; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide	1984
Response to Sinemet 25/100 in Parkinson's disease. Advances in neurology, 1984, Volume: 40 Topics: Aged; Benserazide; Body Weight; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Sex Factors	1984
What to do when Sinemet fails: Part one. Clinical neuropharmacology, 1984, Volume: 7, Issue:2 Topics: Antiparkinson Agents; Carbidopa; Dementia; Drug Administration Schedule; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced	1984
Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment. Neurology, 1982, Volume: 32, Issue:5 Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Amphetamines; Biogenic Amines; Carbidopa; Depression; Drug Combinations; Female; Humans; Levodopa; Male; Methamphetamine; Middle Aged; Monoamine Oxidase; Parkinson Disease; Phenethylamines; Selegiline; Tyramine	1982
Thyrotrophin and prolactin responses to thyrotrophin-releasing hormone in patients with Parkinson's disease. Acta endocrinologica, 1982, Volume: 99, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine	1982
Pergolide mesylate and idiopathic Parkinson disease. Neurology, 1982, Volume: 32, Issue:10 Topics: Adolescent; Adult; Carbidopa; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Parkinson Disease; Pergolide	1982
Further studies with pergolide in Parkinson disease. Neurology, 1982, Volume: 32, Issue:10 Topics: Adult; Aged; Carbidopa; Confusion; Drug Combinations; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide	1982
Prolactin response to acute administration of different L-dopa plus decarboxylase inhibitors in Parkinson's disease. Neuropsychobiology, 1982, Volume: 8, Issue:2 Topics: Aged; Animals; Benserazide; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Rats	1982
Adverse interaction of levodopa with tricyclic antidepressants. The Practitioner, 1982, Volume: 226, Issue:1370 Topics: Aged; Amitriptyline; Carbidopa; Drug Combinations; Drug Interactions; Female; Humans; Imipramine; Levodopa; Parkinson Disease	1982
Drug-induced asterixis in Parkinson disease. Neurology, 1982, Volume: 32, Issue:5 Topics: Aged; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Middle Aged; Muscle Contraction; Muscular Diseases; Parkinson Disease; Posture	1982
Sinemet - 25/100. The Medical letter on drugs and therapeutics, 1980, Jun-13, Volume: 22, Issue:12 Topics: Carbidopa; Drug Combinations; Humans; Levodopa; Parkinson Disease	1980
Contemporaneous bilateral postero-ventral pallidotomy for early onset "juvenile type" Parkinson's disease. Case report. Acta neurochirurgica, 1994, Volume: 131, Issue:3-4 Topics: Antiparkinson Agents; Brain Mapping; Carbidopa; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Postoperative Complications	1994
Adverse reactions to controlled release levodopa/carbidopa in older persons: case reports. Journal of the American Geriatrics Society, 1995, Volume: 43, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Frail Elderly; Hallucinations; Humans; Levodopa; Male; Mental Status Schedule; Parkinson Disease; Severity of Illness Index	1995
Anticholinergics and dyskinesia. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:6 Topics: Aged; Biperiden; Carbidopa; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Tremor; Trihexyphenidyl	1994
Parkinson's disease: reorganization of the reach to grasp movement in response to perturbation of the distal motor patterning. Neuropsychologia, 1994, Volume: 32, Issue:11 Topics: Aged; Antiparkinson Agents; Attention; Carbidopa; Drug Combinations; Female; Hand Strength; Humans; Kinesthesis; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Orientation; Parkinson Disease; Psychomotor Performance; Reaction Time; Selegiline; Size Perception	1994
Portable device for quantifying parkinsonian wrist rigidity. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Muscle Tonus; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Psychotic Disorders; Risk Factors; Transducers	1994
Parkinson's disease: making the diagnosis, selecting drug therapies. Geriatrics, 1994, Volume: 49, Issue:10 Topics: Aged; Antiparkinson Agents; Carbidopa; Cholinergic Antagonists; Diagnosis, Differential; Dopamine Agonists; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1994
First emergence of "delayed-on" and "dose failure" phenomena in a patient with Parkinson's disease following vagotomy. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:5 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Duodenal Ulcer; Female; Gastric Emptying; Gastrointestinal Transit; Humans; Levodopa; Middle Aged; Parkinson Disease; Postoperative Complications; Vagotomy; Vagus Nerve	1994
Drugs for Parkinson's disease. The Medical letter on drugs and therapeutics, 1993, Apr-16, Volume: 35, Issue:894 Topics: Carbidopa; Dopamine Agents; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline	1993
Individualizing therapy in patients with disabling Parkinson's disease symptoms. Neurology, 1994, Volume: 44, Issue:3 Suppl 1 Topics: Aged; Aged, 80 and over; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Middle Aged; Parkinson Disease	1994
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:2 Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Chorea; Circadian Rhythm; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1994
The influence of a standard meal on Sinemet CR absorption in patients with Parkinson's disease. Clinical neurology and neurosurgery, 1993, Volume: 95, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dietary Proteins; Drug Administration Schedule; Drug Combinations; Eating; Female; Humans; Intestinal Absorption; Levodopa; Male; Metabolic Clearance Rate; Middle Aged; Neurologic Examination; Parkinson Disease	1993
Continuous duodenal infusions of levodopa. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 1993, Volume: 25, Issue:5 Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Duodenum; Female; Humans; Intubation, Gastrointestinal; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Patient Education as Topic	1993
Levodopa pharmacodynamics. Neurology, 1994, Volume: 44, Issue:2 Topics: Carbidopa; Drug Combinations; Drugs, Generic; Humans; Levodopa; Parkinson Disease; United States; United States Food and Drug Administration	1994
Suppression of dyskinesias in advanced Parkinson's disease. I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease. Neurology, 1993, Volume: 43, Issue:8 Topics: Aged; Antiparkinson Agents; Carbidopa; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Tyrosine	1993
Risk factors for motor response complications in L-dopa-treated parkinsonian patients. Advances in neurology, 1993, Volume: 60 Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Motor Activity; Neurologic Examination; Parkinson Disease; Risk Factors	1993
Treatment of drug-induced psychosis in Parkinson's disease with clozapine. Advances in neurology, 1993, Volume: 60 Topics: Aged; Antiparkinson Agents; Carbidopa; Clozapine; Dementia; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Psychoses, Substance-Induced	1993
Plasma levels of levodopa and its main metabolites in parkinsonian patients after conventional and controlled-release levodopa-carbidopa associations. European neurology, 1993, Volume: 33, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Antiparkinson Agents; Blood-Brain Barrier; Carbidopa; Delayed-Action Preparations; Dopamine; Dose-Response Relationship, Drug; Drug Combinations; Female; Homovanillic Acid; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Tyrosine	1993
Clinical experience with controlled-release carbidopa/levodopa in Parkinson's disease. Neurology, 1993, Volume: 43, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Satisfaction; Treatment Outcome	1993
Determination of tetrahydropapaveroline in the urine of parkinsonian patients receiving L-dopa-carbidopa (Sinemet) therapy by high-performance liquid chromatography. Journal of chromatography, 1993, Apr-02, Volume: 613, Issue:2 Topics: Adsorption; Aluminum Oxide; Antiparkinson Agents; Carbidopa; Cation Exchange Resins; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Drug Combinations; Electrochemistry; Humans; Levodopa; Parkinson Disease; Resins, Synthetic; Silanes; Tetrahydropapaveroline	1993
Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use. Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:1 Topics: Antiparkinson Agents; Ascorbic Acid; Carbidopa; Drug Combinations; Drug Stability; Drug Storage; Humans; Levodopa; Light; Parkinson Disease; Temperature; Time Factors	1996
Amantadine-induced "vocal" myoclonus. Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:1 Topics: Aged; Amantadine; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Dysarthria; Female; Humans; Levodopa; Myoclonus; Neurologic Examination; Parkinson Disease; Verbal Behavior	1996
Levodopa in pregnancy. Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:1 Topics: Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Infant, Newborn; Levodopa; Parkinson Disease; Pregnancy; Pregnancy Complications; Risk Factors	1996
Supplement: treatment for Parkinson's disease. Neurology, 1995, Volume: 45, Issue:12 Topics: Algorithms; Antiparkinson Agents; Carbidopa; Drug Combinations; Humans; Levodopa; Middle Aged; Parkinson Disease	1995
Triphasic waves in serotonin syndrome. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 62, Issue:2 Topics: 1-Naphthylamine; Aged; Amantadine; Antiparkinson Agents; Brain Diseases; Carbidopa; Drug Combinations; Drug Therapy, Combination; Electroencephalography; Hallucinations; Humans; Levodopa; Male; Myoclonus; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Sertraline; Syndrome	1997
Comparison of utilization of Sinemet and Parkinson's disease mortality as surrogate indicators of Parkinson's disease in the United States. Journal of the neurological sciences, 1997, Volume: 145, Issue:1 Topics: Antiparkinson Agents; Carbidopa; Demography; Drug Combinations; Drug Utilization; Humans; Levodopa; Linear Models; Parkinson Disease; United States	1997
The nurse's role in clinical trials. The Canadian nurse, 1996, Volume: 92, Issue:10 Topics: Antiparkinson Agents; Carbidopa; Clinical Trials, Phase IV as Topic; Drug Combinations; Humans; Job Description; Levodopa; Nursing Care; Parkinson Disease	1996
Clinical implications of sustained dopaminergic stimulation. Clinical neuropharmacology, 1994, Volume: 17 Suppl 2 Topics: Aged; Benserazide; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Levodopa; Lisuride; Parkinson Disease; Reaction Time	1994
Treatment with AC pulsed electromagnetic fields improves the response to levodopa in Parkinson's disease. The International journal of neuroscience, 1997, Volume: 91, Issue:3-4 Topics: Antiparkinson Agents; Carbidopa; Circadian Rhythm; Combined Modality Therapy; Drug Combinations; Electromagnetic Fields; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1997
Square-wave action dystonia in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:2 Topics: Antiparkinson Agents; Carbidopa; Dominance, Cerebral; Drug Combinations; Dystonia; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1998
The co-ordination and phasing of a bilateral prehension task. The influence of Parkinson's disease. Brain : a journal of neurology, 1998, Volume: 121 ( Pt 4) Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Functional Laterality; Hand Strength; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance; Reaction Time; Reference Values	1998
Highlights of the North American and European experiences. Neurology, 1998, Volume: 50, Issue:5 Suppl 5 Topics: Antiparkinson Agents; Benserazide; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Dopamine Agents; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Humans; Levodopa; Nitrophenols; North America; Parkinson Disease; Randomized Controlled Trials as Topic; Tolcapone	1998
Quality of life and Parkinson's disease: the CR FIRST Study. Journal of neurology, 1998, Volume: 245 Suppl 1 Topics: Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Emotions; Humans; Levodopa; Parkinson Disease; Quality of Life; Social Isolation; Treatment Outcome	1998
Levodopa in human breast milk: clinical implications. Neurology, 1998, Volume: 50, Issue:6 Topics: Adult; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Lactation; Levodopa; Milk, Human; Osmolar Concentration; Parkinson Disease	1998
Early-occurrence of manual motor blocks in Parkinson's disease: a quantitative assessment. Acta neurologica Scandinavica, 1999, Volume: 99, Issue:2 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gait; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Psychomotor Disorders; Treatment Outcome	1999
Successful orchestration of antiparkinsonian pharmacotherapy. Pharmacotherapy, 1999, Volume: 19, Issue:11 Pt 2 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Comorbidity; Disease Progression; Drug Combinations; Dyskinesias; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pharmacists	1999
Striatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Brain Mapping; Carbidopa; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Drug Combinations; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Raclopride; Receptors, Dopamine D2; Tomography, Emission-Computed	1999
The reach-to-grasp movement in Parkinson's disease before and after dopaminergic medication. Neuropsychologia, 2000, Volume: 38, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Basal Ganglia; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychomotor Performance; Reaction Time; Receptors, Dopamine	2000
The effect of pregnancy in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:1 Topics: Adult; Antiparkinson Agents; Carbidopa; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Infant, Newborn; Levodopa; Neurologic Examination; Parkinson Disease; Pregnancy; Pregnancy Complications; Quality of Life	2000
Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease. The Journal of clinical endocrinology and metabolism, 1978, Volume: 47, Issue:4 Topics: Adult; Aged; Carbidopa; Circadian Rhythm; Drug Combinations; Drug Therapy, Combination; Ergolines; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Sleep	1978
Clozapine for the treatment of levodopa-induced psychosis in Parkinson's disease. General hospital psychiatry, 1992, Volume: 14, Issue:4 Topics: Antiparkinson Agents; Carbidopa; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Paranoid Disorders; Parkinson Disease; Psychoses, Substance-Induced	1992
Lack of changes in ventricular cerebrospinal fluid concentrations of homovanillic acid following acute challenge with levodopa. Annals of neurology, 1992, Volume: 31, Issue:1 Topics: Aged; Carbidopa; Cerebral Ventricles; Drug Combinations; Female; Homovanillic Acid; Humans; Hydrocephalus, Normal Pressure; Levodopa; Male; Middle Aged; Parkinson Disease	1992
Sensorimotor disinhibition in Parkinson's disease: effects of levodopa. Annals of neurology, 1992, Volume: 31, Issue:1 Topics: Carbidopa; Drug Combinations; Hand; Humans; Levodopa; Male; Motor Activity; Parkinson Disease; Psychomotor Performance; Reaction Time	1992
The use of Sinemet CR in the management of mild to moderate Parkinson's disease. Neurology, 1992, Volume: 42, Issue:1 Suppl 1 Topics: Carbidopa; Drug Administration Schedule; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Movement; Parkinson Disease; Patient Compliance; Patient Education as Topic; Tissue Distribution	1992
Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration. Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:1 Topics: Aged; Antiparkinson Agents; Atrophy; Brain; Carbidopa; Central Nervous System Diseases; Chorea; Diagnosis, Differential; Drug Combinations; Female; Humans; Levodopa; Movement Disorders; Nerve Degeneration; Parkinson Disease; Spinal Cord	1992
Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide) Archives of neurology, 1992, Volume: 49, Issue:5 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Lactose; Levodopa; Male; Methylcellulose; Middle Aged; Oxazines; Parkinson Disease; Pergolide	1992
Unforeseen beneficial effects of controlled-release levodopa-carbidopa (Sinemet CR) The Journal of neuropsychiatry and clinical neurosciences, 1992,Spring, Volume: 4, Issue:2 Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease	1992
Protein redistribution diet remains effective in patients with fluctuating parkinsonism. Archives of neurology, 1992, Volume: 49, Issue:2 Topics: Adult; Aged; Amino Acids; Antiparkinson Agents; Brain; Carbidopa; Dietary Proteins; Drug Combinations; Humans; Levodopa; Middle Aged; Parkinson Disease	1992
Levodopa-associated hemifacial dystonia. Movement disorders : official journal of the Movement Disorder Society, 1991, Volume: 6, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Dystonia; Facial Muscles; Female; Humans; Levodopa; Parkinson Disease; Putamen	1991
Autologous adrenal medullary transplants in advanced Parkinson's disease with particular attention to the selective improvement in symptoms. Stereotactic and functional neurosurgery, 1991, Volume: 57, Issue:4 Topics: Adrenal Medulla; Adult; Antiparkinson Agents; Carbidopa; Caudate Nucleus; Combined Modality Therapy; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis; Time Factors; Tomography, X-Ray Computed; Transplantation, Heterotopic	1991
Sinemet (CR4): an open-label study in moderately severe Parkinson's disease. Journal of internal medicine, 1991, Volume: 230, Issue:2 Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1991
Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation. Journal of neurology, neurosurgery, and psychiatry, 1991, Volume: 54, Issue:7 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Cerebral Cortex; Cognition Disorders; Dopamine; Dose-Response Relationship, Drug; Drug Combinations; Electroencephalography; Evoked Potentials; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Psychomotor Performance; Reaction Time; Receptors, Dopamine	1991
Sinemet CR for Parkinson's disease. The Medical letter on drugs and therapeutics, 1991, Oct-04, Volume: 33, Issue:854 Topics: Carbidopa; Delayed-Action Preparations; Drug Combinations; Humans; Levodopa; Parkinson Disease	1991
Treating the progressive stages of Parkinson's disease. Postgraduate medicine, 1991, Volume: 90, Issue:1 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Pergolide; Selegiline	1991
Dopamine sulfate in ventricular cerebrospinal fluid and motor function in Parkinson's disease. Neurology, 1991, Volume: 41, Issue:10 Topics: Carbidopa; Cerebral Ventricles; Dopamine; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Movement; Parkinson Disease; Sulfates	1991
Sustained-release (+)-PHNO [MK-458 (HPMC)] in the treatment of Parkinson's disease: evidence for tolerance to a selective D2-receptor agonist administered as a long-acting formulation. Movement disorders : official journal of the Movement Disorder Society, 1990, Volume: 5, Issue:4 Topics: Activities of Daily Living; Antiparkinson Agents; Brain; Carbidopa; Delayed-Action Preparations; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Oxazines; Parkinson Disease; Receptors, Dopamine; Receptors, Dopamine D2	1990
Off-period screaming accompanying motor fluctuations in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1991, Volume: 6, Issue:1 Topics: Antiparkinson Agents; Carbidopa; Crying; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Middle Aged; Parkinson Disease; Receptors, Dopamine	1991
New drugs for Parkinson's disease. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 1990, Volume: 22, Issue:4 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phenethylamines; Quality of Life; Selegiline	1990
Utilization of unilateral and bilateral stereotactically placed adrenomedullary-striatal autografts in parkinsonian humans: rationale, techniques, and observations. Neurosurgery, 1990, Volume: 26, Issue:5 Topics: Adrenal Medulla; Adult; Aged; Antiparkinson Agents; Carbidopa; Corpus Striatum; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Neurosurgery; Parkinson Disease; Postoperative Complications; Stereotaxic Techniques; Tomography, X-Ray Computed	1990
A view from inside. British dental journal, 1990, Sep-22, Volume: 169, Issue:6 Topics: Accidental Falls; Antiparkinson Agents; Bromocriptine; Carbidopa; Dentists; Drug Combinations; Humans; Levodopa; Male; Northern Ireland; Parkinson Disease	1990
Neuroleptic malignant syndrome without neuroleptics. Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:6 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan	1990
Sinemet-ferrous sulphate interaction in patients with Parkinson's disease. British journal of clinical pharmacology, 1990, Volume: 30, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Biological Availability; Carbidopa; Drug Combinations; Drug Interactions; Female; Ferrous Compounds; Humans; Levodopa; Male; Middle Aged; Oxygen; Parkinson Disease	1990
Pharmacodynamic modeling of concentration-effect relationships after controlled-release carbidopa/levodopa (Sinemet CR4) in Parkinson's disease. Neurology, 1990, Volume: 40, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Linear Models; Male; Middle Aged; Models, Biological; Parkinson Disease	1990
Treatment of Parkinson's disease. Neurology, 1990, Volume: 40, Issue:4 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease	1990
Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia. Journal of neurology, neurosurgery, and psychiatry, 1990, Volume: 53, Issue:3 Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Carboxy-Lyases; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Hydrazines; Levodopa; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease	1990
Steady plasma levodopa concentrations required for good clinical response to CR-4 in patients with 'on-off'. European neurology, 1990, Volume: 30, Issue:2 Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1990
Marijuana for parkinsonian tremor. Journal of neurology, neurosurgery, and psychiatry, 1990, Volume: 53, Issue:5 Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Diazepam; Drug Combinations; Humans; Levodopa; Marijuana Smoking; Parkinson Disease; Tremor	1990
Selegiline in the treatment of Parkinson's disease--long term experience. Acta neurologica Scandinavica. Supplementum, 1989, Volume: 126 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Phenethylamines; Selegiline	1989
Dopamine and memory function in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1989, Volume: 4, Issue:2 Topics: Aged; Attention; Brain; Carbidopa; Dopamine; Drug Combinations; Female; Humans; Levodopa; Male; Memory; Mental Recall; Middle Aged; Motor Skills; Neuropsychological Tests; Parkinson Disease; Pattern Recognition, Visual; Receptors, Dopamine; Synaptic Transmission; Verbal Learning	1989
Clinical and pharmacokinetic evaluation of controlled-release levodopa/carbidopa (CR-4) in parkinsonian patients with severe motor fluctuations: a six month follow-up study. Clinical neurology and neurosurgery, 1989, Volume: 91, Issue:4 Topics: Adult; Aged; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1989
New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation. London, England, April 28 and 29, 1989. Proceedings. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Humans; Levodopa; Parkinson Disease	1989
A pharmacokinetic and pharmacodynamic comparison of Sinemet CR (50/200) and standard Sinemet (25/100). Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tyrosine	1989
Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease; Psychomotor Performance	1989
Effect of controlled-release carbidopa/levodopa on motor performance in advanced Parkinson's disease. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Administration, Oral; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance; Tablets	1989
Treatment of early Parkinson's disease with controlled-release levodopa preparations. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Parkinson Disease	1989
Sinemet CR in the treatment of patients with Parkinson's disease already on long-term treatment with levodopa. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1989
Experiences with Sinemet CR in the Paracelsus-Elena-Klinik. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Humans; Levodopa; Middle Aged; Parkinson Disease	1989
Long-term clinical efficacy of Sinemet CR in patients with Parkinson's disease. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Follow-Up Studies; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease	1989
Adrenal medullary autograft transplantation into the striatum of patients with Parkinson's disease. Mayo Clinic proceedings, 1989, Volume: 64, Issue:3 Topics: Adrenal Medulla; Adult; Carbidopa; Caudate Nucleus; Drug Combinations; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Postoperative Complications; Stereotaxic Techniques	1989
Correlates of memory in Parkinson's disease. The Journal of nervous and mental disease, 1989, Volume: 177, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Amantadine; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Memory; Memory Disorders; Middle Aged; Movement Disorders; Neuropsychological Tests; Parkinson Disease	1989
Efficacy of sinemet CR4 in subgroups of patients with Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:1 Topics: Activities of Daily Living; Adult; Aged; Biological Availability; Carbidopa; Corpus Striatum; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease	1989
Disability profiles and objective quantitative assessment in Parkinson's disease. Acta neurologica Scandinavica, 1989, Volume: 79, Issue:3 Topics: Adult; Aged; Benserazide; Carbidopa; Disability Evaluation; Drug Combinations; Female; Humans; Levodopa; Locomotion; Male; Middle Aged; Parkinson Disease; Posture; Psychomotor Performance; Reaction Time	1989
Pharmacokinetic and pharmacodynamic modeling of L-dopa plasma concentrations and clinical effects in Parkinson's disease after Sinemet. Clinical neuropharmacology, 1989, Volume: 12, Issue:2 Topics: Adult; Aged; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Mathematics; Middle Aged; Models, Theoretical; Parkinson Disease	1989
An open trial of controlled release carbidopa/L-dopa (sinemet CR) for the treatment of mild-to-moderate Parkinson's disease. Clinical neuropharmacology, 1989, Volume: 12, Issue:3 Topics: Aged; Carbidopa; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1989
(+)-4-Propyl-9-hydroxynaphthoxazine in Parkinson's disease. Lancet (London, England), 1986, Apr-19, Volume: 1, Issue:8486 Topics: Animals; Callithrix; Carbidopa; Domperidone; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Oxazines; Parkinson Disease; Time Factors	1986
Painful Parkinson's disease. Lancet (London, England), 1986, Jun-14, Volume: 1, Issue:8494 Topics: Acute Disease; Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Administration Schedule; Drug Combinations; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Pain; Parkinson Disease; Time Factors	1986
Parkinson's disease, depression, and the on-off phenomenon. Psychosomatics, 1989,Winter, Volume: 30, Issue:1 Topics: Bromocriptine; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease	1989
Dose-dependent memory impairment in Parkinson's disease. Neurology, 1989, Volume: 39, Issue:3 Topics: Carbidopa; Dopamine; Drug Combinations; Humans; Levodopa; Memory Disorders; Parkinson Disease	1989
Comprehensive care of the patient with Parkinson's disease. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 1986, Volume: 18, Issue:3 Topics: Aged; Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Patient Care Planning; Patient Care Team; Tremor	1986
[Therapeutic strategies and tactics in parkinsonism]. Wiener medizinische Wochenschrift (1946), 1986, Aug-31, Volume: 136, Issue:15-16 Topics: Amantadine; Antidepressive Agents; Antiparkinson Agents; Benserazide; Carbidopa; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Motor Skills; Parkinson Disease; Selegiline; Sleep Initiation and Maintenance Disorders	1986
Drugs for parkinsonism. The Medical letter on drugs and therapeutics, 1988, Dec-16, Volume: 30, Issue:781 Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline	1988
Drug-induced alzheimerism. Archives of neurology, 1988, Volume: 45, Issue:3 Topics: Aged; Alzheimer Disease; Biperiden; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Parkinson Disease; Piperidines	1988
Controlled-release levodopa/carbidopa. III: Sinemet CR5 treatment of response fluctuations in Parkinson's disease. Clinical neuropharmacology, 1988, Volume: 11, Issue:2 Topics: Aged; Antiparkinson Agents; Biological Availability; Carbidopa; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Humans; Levodopa; Parkinson Disease	1988
False positive diagnosis of phaeochromocytoma in a patient with Parkinson's disease receiving levodopa. Journal of neurology, neurosurgery, and psychiatry, 1988, Volume: 51, Issue:5 Topics: Adrenal Gland Neoplasms; Aged; Carbidopa; Diagnostic Errors; Drug Combinations; Female; Humans; Levodopa; Parkinson Disease; Pheochromocytoma; Vanilmandelic Acid	1988
[Cholestasis caused by Nakom]. Klinicheskaia meditsina, 1988, Volume: 66, Issue:5 Topics: Antiparkinson Agents; Carbidopa; Cholestasis; Diagnosis, Differential; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1988
Mood swings associated with the 'on-off' phenomenon in Parkinson's disease. Psychological medicine, 1987, Volume: 17, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Parkinson Disease; Parkinson Disease, Secondary	1987
Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period. Movement disorders : official journal of the Movement Disorder Society, 1986, Volume: 1, Issue:1 Topics: Aged; Carbidopa; Drug Combinations; Humans; Levodopa; Locus Coeruleus; Male; Parkinson Disease; Substantia Nigra	1986
Controlled release levodopa treatment of motor fluctuations in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1987, Volume: 50, Issue:2 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance	1987
A case of normal pressure hydrocephalus presenting as levodopa responsive parkinsonism. Journal of neurology, neurosurgery, and psychiatry, 1987, Volume: 50, Issue:2 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Hydrocephalus; Hydrocephalus, Normal Pressure; Levodopa; Middle Aged; Parkinson Disease	1987
Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet). Neurology, 1987, Volume: 37, Issue:5 Topics: Adult; Aged; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease	1987
Stridor during dystonic phases of Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1987, Volume: 50, Issue:6 Topics: Adult; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Respiratory Sounds	1987
Controlled-release Sinemet. Neurology, 1987, Volume: 37, Issue:9 Topics: Carbidopa; Delayed-Action Preparations; Drug Combinations; Humans; Levodopa; Parkinson Disease	1987
Controlled-release levodopa/carbidopa. II. Sinemet CR4 treatment of response fluctuations in Parkinson's disease. Neurology, 1987, Volume: 37, Issue:10 Topics: Carbidopa; Delayed-Action Preparations; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Paranoid Disorders; Parkinson Disease; Patient Acceptance of Health Care; Time Factors	1987
Sinemet in Parkinson's disease: efficacy with and without food. Clinical neuropharmacology, 1986, Volume: 9, Issue:2 Topics: Administration, Oral; Aged; Antiparkinson Agents; Carbidopa; Diet; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1986
Pharmacotherapy: problems and practices. Clinical neuropharmacology, 1986, Volume: 9 Suppl 1 Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease	1986
L-dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine. Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:3 Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Drug Interactions; Humans; Levodopa; Male; Myoclonus; Parkinson Disease; Serotonin	1986
Drugs for parkinsonism. The Medical letter on drugs and therapeutics, 1986, Jun-20, Volume: 28, Issue:716 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease	1986
Management of Parkinson's disease in general practice. Scottish medical journal, 1986, Volume: 31, Issue:2 Topics: Aged; Benserazide; Bromocriptine; Carbidopa; Drug Combinations; Family Practice; Humans; Levodopa; Medical Audit; Parkinson Disease	1986
Clinical and biochemical studies with controlled-release levodopa/carbidopa. Neurology, 1986, Volume: 36, Issue:9 Topics: Aged; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1986
Controlled-release levodopa/carbidopa. I. Sinemet CR3 treatment of response fluctuations in Parkinson's disease. Neurology, 1987, Volume: 37, Issue:2 Topics: Adult; Aged; Antiparkinson Agents; Biological Availability; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Nervous System Diseases; Parkinson Disease	1987
Alleviation of severe emotional symptoms by carbidopa-levodopa, MSD, in a Parkinson's patient: a personal report. The Journal of nervous and mental disease, 1987, Volume: 175, Issue:3 Topics: Affective Symptoms; Aged; Carbidopa; Dopamine; Drug Combinations; Emotions; Humans; Levodopa; Male; Parkinson Disease	1987
Low-dosage treatment in de novo patients with Parkinson's disease: a prospective study. Advances in neurology, 1987, Volume: 45 Topics: Aged; Bromocriptine; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Orphenadrine; Parkinson Disease	1987
Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology, 1985, Volume: 35, Issue:7 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acute Disease; Adult; Carbidopa; Chronic Disease; Drug Combinations; Female; Humans; Levodopa; Male; Parkinson Disease; Pyridines; Substance-Related Disorders; Substantia Nigra	1985
Pharmacologic treatment of parkinsonian tremor. Archives of neurology, 1986, Volume: 43, Issue:2 Topics: Amantadine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tremor; Trihexyphenidyl	1986
Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause. Neurology, 1985, Volume: 35, Issue:2 Topics: Body Temperature Regulation; Bromocriptine; Carbidopa; Drug Combinations; Female; Fever; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Receptors, Dopamine	1985
Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study. Neurology, 1985, Volume: 35, Issue:4 Topics: Aged; Carbidopa; Drug Combinations; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Receptors, Dopamine; Sleep Wake Disorders; Sleep, REM	1985
[Drug therapy of Parkinson's disease]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1985, Volume: 18, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1985
[Clinical significance of cramps of the lower extremities in patients with parkinsonism]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1985, Volume: 18, Issue:4 Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Leg; Levodopa; Male; Middle Aged; Muscle Cramp; Parkinson Disease	1985